<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75140</article-id><article-id pub-id-type="doi">10.7554/eLife.75140</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Shank promotes action potential repolarization by recruiting BK channels to calcium microdomains</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-259695"><name><surname>Gao</surname><given-names>Luna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149377"><name><surname>Zhao</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259696"><name><surname>Ardiel</surname><given-names>Evan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-61278"><name><surname>Hall</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-61279"><name><surname>Nurrish</surname><given-names>Stephen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2653-9384</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-177090"><name><surname>Kaplan</surname><given-names>Joshua M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7418-7179</contrib-id><email>kaplan@molbio.mgh.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/002pd6e78</institution-id><institution>Department of Molecular Biology, Massachusetts General Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Department of Neurobiology, Harvard Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Program in Neuroscience, Harvard Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Davis</surname><given-names>Graeme W</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>University of California, San Francisco</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Sengupta</surname><given-names>Piali</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>03</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e75140</elocation-id><history><date date-type="received" iso-8601-date="2021-10-30"><day>30</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-03-09"><day>09</day><month>03</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-11-05"><day>05</day><month>11</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.11.05.467415"/></event></pub-history><permissions><copyright-statement>© 2022, Gao et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Gao et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75140-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-75140-figures-v2.pdf"/><abstract><p>Mutations altering the scaffolding protein Shank are linked to several psychiatric disorders, and to synaptic and behavioral defects in mice. Among its many binding partners, Shank directly binds CaV1 voltage activated calcium channels. Here, we show that the <italic>Caenorhabditis elegans</italic> SHN-1/Shank promotes CaV1 coupling to calcium activated potassium channels. Mutations inactivating SHN-1, and those preventing SHN-1 binding to EGL-19/CaV1 all increase action potential durations in body muscles. Action potential repolarization is mediated by two classes of potassium channels: SHK-1/KCNA and SLO-1 and SLO-2 BK channels. BK channels are calcium-dependent, and their activation requires tight coupling to EGL-19/CaV1 channels. SHN-1’s effects on AP duration are mediated by changes in BK channels. In <italic>shn-1</italic> mutants, SLO-2 currents and channel clustering are significantly decreased in both body muscles and neurons. Finally, increased and decreased <italic>shn-1</italic> gene copy number produce similar changes in AP width and SLO-2 current. Collectively, these results suggest that an important function of Shank is to promote microdomain coupling of BK with CaV1.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>shank</kwd><kwd>SHN-1</kwd><kwd>BK channel</kwd><kwd>SLO-1</kwd><kwd>SLO-2</kwd><kwd>action potential</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS32196</award-id><principal-award-recipient><name><surname>Kaplan</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Shank promotes functional coupling between CaV1 calcium channels and BK potassium channels.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Shank is a synaptic scaffolding protein (containing SH3, PDZ, proline-rich and SAM domains) (<xref ref-type="bibr" rid="bib26">Grabrucker et al., 2011</xref>). Mammals have three Shank genes, each encoding multiple isoforms (<xref ref-type="bibr" rid="bib33">Jiang and Ehlers, 2013</xref>). Several mouse Shank knockouts have been described but these mutants exhibit inconsistent (often contradictory) synaptic and behavioral defects (<xref ref-type="bibr" rid="bib33">Jiang and Ehlers, 2013</xref>), most likely resulting from differences in the Shank isoforms impacted by each mutation. The biochemical mechanism by which Shank mutations alter synaptic function and behavior has not been determined.</p><p>In humans, Shank mutations and CNVs are linked to Autism Spectrum Disorders (ASD), schizophrenia, and mania (<xref ref-type="bibr" rid="bib15">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="bib48">Peça et al., 2011</xref>). Haploinsufficiency for 22q13 (which spans the Shank3 locus) occurs in Phelan-McDermid syndrome (PMS), a syndromic form of ASD (<xref ref-type="bibr" rid="bib52">Phelan and McDermid, 2012</xref>). PMS patients exhibit autistic behaviors accompanied by hypotonia, delayed speech, and intellectual disability (ID) (<xref ref-type="bibr" rid="bib8">Bonaglia et al., 2011</xref>). Heterozygous inactivating Shank3 mutations are found in sporadic ASD and schizophrenia (<xref ref-type="bibr" rid="bib15">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="bib48">Peça et al., 2011</xref>). A parallel set of genetic studies suggest that increased Shank3 function also contributes to psychiatric diseases. 22q13 duplications spanning Shank3 are found in ASD, schizophrenia, ADHD, and bipolar disorder (<xref ref-type="bibr" rid="bib15">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="bib17">Failla et al., 2007</xref>; <xref ref-type="bibr" rid="bib28">Han et al., 2013</xref>). A transgenic mouse that selectively over-expresses Shank3 exhibits hyperactive behavior and susceptibility to seizures (<xref ref-type="bibr" rid="bib28">Han et al., 2013</xref>). Taken together, these studies suggest that too little or too much Shank3 can contribute to the pathophysiology underlying these psychiatric disorders.</p><p>Given its link to psychiatric disorders, there is great interest in determining how Shank regulates circuit development and function. Shank is highly enriched in the post-synaptic densities of excitatory synapses; consequently, most studies have focused on the idea that Shank proteins regulate some aspect of synapse formation or function. Through its various domains, Shank proteins bind many proteins (<xref ref-type="bibr" rid="bib40">Lee et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Sakai et al., 2011</xref>), thereby potentially altering diverse cellular functions. Shank proteins have been implicated in activity induced gene transcription (<xref ref-type="bibr" rid="bib50">Perfitt et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>), synaptic transmission (<xref ref-type="bibr" rid="bib75">Zhou et al., 2016</xref>), synapse maturation (<xref ref-type="bibr" rid="bib30">Harris et al., 2016</xref>), synaptic homeostasis (<xref ref-type="bibr" rid="bib66">Tatavarty et al., 2020</xref>), cytoskeletal remodeling (<xref ref-type="bibr" rid="bib41">Lilja et al., 2017</xref>), and sleep (<xref ref-type="bibr" rid="bib31">Ingiosi et al., 2019</xref>). Each of these defects could contribute to the neurodevelopmental and cognitive deficits observed in ASD and schizophrenia.</p><p>Several recent studies suggest that an important function of Shank is to regulate the subcellular localization of ion channels. Shank mutations decrease the synaptic localization of NMDA and AMPA type glutamate receptors (<xref ref-type="bibr" rid="bib48">Peça et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Won et al., 2012</xref>). Other studies show that Shank proteins promote delivery of several ion channels to the plasma membrane, including HCN channels (<xref ref-type="bibr" rid="bib72">Yi et al., 2016</xref>; <xref ref-type="bibr" rid="bib76">Zhu et al., 2018</xref>), TRPV channels (<xref ref-type="bibr" rid="bib29">Han et al., 2016</xref>), and CaV1 voltage activated calcium channels (<xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2017</xref>). Of these potential binding partners, we focus on CaV1 because human CACNA1C (which encodes a CaV1 α-subunit) is mutated in Timothy Syndrome (TS), a rare monogenic form of ASD (<xref ref-type="bibr" rid="bib63">Splawski et al., 2005</xref>; <xref ref-type="bibr" rid="bib62">Splawski et al., 2004</xref>), and polymorphisms linked to CACNA1C are associated with multiple psychiatric disorders (<xref ref-type="bibr" rid="bib54">Psychiatric Genomics, 2013</xref>). For this reason, we asked how Shank regulates the coupling of CaV1 channels to their downstream effectors.</p><p><italic>C. elegans</italic> has a single Shank gene, <italic>shn-1</italic>. The SHN-1 protein lacks an SH3 domain but has all other domains found in mammalian Shank proteins. Mammalian Shank proteins directly bind CaV1 channels through both the SH3 and PDZ domains (<xref ref-type="bibr" rid="bib74">Zhang et al., 2005</xref>). We previously showed that the SHN-1 PDZ domain directly binds to a carboxy-terminal ligand in EGL-19/CaV1 (<xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>). CaV1 channels are tightly coupled to multiple downstream calcium activated pathways. <italic>C. elegans</italic> and mouse Shank proteins have been shown to promote CaV1-mediated activation of the transcription factor CREB (<xref ref-type="bibr" rid="bib50">Perfitt et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>).</p><p>Here, we test the idea that SHN-1 regulates CaV1 coupling to a second effector, calcium activated potassium currents (which are mediated by BK channels). BK channels are activated by both membrane depolarization and by cytoplasmic calcium. At resting cytoplasmic calcium levels (~100 nM), BK channels have extremely low open probability. Following depolarization, cytoplasmic calcium rises thereby activating BK channels. BK channels bind calcium with a K<sub>d</sub> ranging from 1 to 10 μM (<xref ref-type="bibr" rid="bib12">Contreras et al., 2013</xref>); consequently, efficient BK channel activation requires tight spatial coupling to voltage activated calcium (CaV) channels. BK channels associate with all classes of CaV channels (<xref ref-type="bibr" rid="bib6">Berkefeld et al., 2006</xref>). The co-clustering of BK and CaV channels allows rapid activation of hyperpolarizing potassium currents following depolarization. BK channels decrease action potential (AP) durations, promote rapid after hyperpolarization potentials, decrease the duration of calcium entry, and limit secretion of neurotransmitters and hormones in neurons and muscles (<xref ref-type="bibr" rid="bib1">Adams et al., 1982</xref>; <xref ref-type="bibr" rid="bib16">Edgerton and Reinhart, 2003</xref>; <xref ref-type="bibr" rid="bib51">Petersen and Maruyama, 1984</xref>; <xref ref-type="bibr" rid="bib64">Storm, 1987</xref>). Thus, BK channels have profound effects on circuit activity.</p><p><italic>C. elegans</italic> has two BK channel subunits (SLO-1 and SLO-2), both of which form calcium and voltage dependent potassium channels when heterologously expressed (<xref ref-type="bibr" rid="bib67">Wang et al., 2001</xref>; <xref ref-type="bibr" rid="bib73">Yuan et al., 2000</xref>). SLO-2 channels are also activated by cytoplasmic chloride (<xref ref-type="bibr" rid="bib73">Yuan et al., 2000</xref>). As in mammals, neuronal SLO-1 and –2 channels inhibit neurotransmitter release (<xref ref-type="bibr" rid="bib44">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="bib57">Sancar et al., 2011</xref>), presumably via their coupling to UNC-2/CaV2 and EGL-19/CaV1. In body muscles, SLO-1 channels are co-localized with EGL-19/CaV1 channels and regulate muscle excitability and behavior (<xref ref-type="bibr" rid="bib35">Kim et al., 2009</xref>). Here we show that SHN-1 promotes BK coupling to EGL-19/CaV1 channels, thereby decreasing AP duration.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>SHN-1 acts in muscles to regulate action potential duration</title><p>EGL-19/CaV1 channels mediate the primary depolarizing current during body muscle APs (<xref ref-type="bibr" rid="bib34">Jospin et al., 2002</xref>; <xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref>). Because SHN-1 directly binds EGL-19 (<xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>), we asked if SHN-1 regulates muscle AP firing patterns. In WT animals, body muscles exhibit a pattern of spontaneous AP bursts (~10 APs/burst; burst frequency 0.1 Hz) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Within a burst, APs became progressively wider (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). A similar pattern of progressive AP broadening during burst firing has been reported for many neurons (<xref ref-type="bibr" rid="bib24">Geiger and Jonas, 2000</xref>; <xref ref-type="bibr" rid="bib32">Jackson et al., 1991</xref>). Outward potassium currents were progressively decreased during repetitive depolarization (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), suggesting that progressive AP broadening most likely results from accumulation of inactivated potassium channels during bursts, as seen in other cell types (<xref ref-type="bibr" rid="bib24">Geiger and Jonas, 2000</xref>; <xref ref-type="bibr" rid="bib36">Kole et al., 2007</xref>). Occasionally, WT muscles also exhibited prolonged depolarizations ( &gt; 150ms), which are hereafter designated plateau potentials (PPs). PPs often occur at the end of an AP burst (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>SHN-1 regulates muscle AP firing patterns.</title><p>(<bold>A</bold>) Representative traces of spontaneous muscle APs are shown for WT and <italic>shn-1(nu712</italic> null) mutants. APs occur in bursts of ~10 APs/ burst. Plateau potentials (PPs), defined as transients lasting &gt;150ms, are observed less frequently, often at the end of a burst. (<bold>B</bold>) APs become progressively longer during bursts. Successive APs taken from a representative burst are shown. (<bold>C</bold>) Repetitive depolarization to +30 mV leads to a progressive decrease in potassium currents. A representative recording from a WT animal is shown. This likely results from an accumulation of inactivated potassium channels during repetitive stimulation. (<bold>D–I</bold>) Mean PP rate (<bold>D</bold>), AP rate (<bold>E</bold>), AP width (<bold>F</bold>), RMP (<bold>G</bold>), AP amplitude (<bold>H</bold>), and input resistance (R<sub>in</sub>, <bold>I</bold>) are compared in WT and <italic>shn-1</italic> null mutants. All <italic>shn-1</italic> data were obtained from <italic>shn-1(nu712</italic>) except for R<sub>in</sub> (<bold>I</bold>), which were from <italic>shn-1(tm488</italic>). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>SHN-1 is expressed in many tissues.</title><p>Endogenous SHN-1 is broadly expressed, including in neurons, muscles, skin, and glia. A representative image of reconstituted fluorescence produced by <italic>shn-1(nu600</italic> GFP<sub>11</sub>) and eft-3&gt;GFP<sub>1-10</sub> (left) and the corresponding bright field image (right) are shown. Pharyngeal muscles (Ph mm) are indicated in the bright field image. SHN-1(GFP<sub>11</sub>) expression in body muscles was not detected, consistent with the very low <italic>shn-1</italic> mRNA levels reported in body muscles (<xref ref-type="bibr" rid="bib10">Cao et al., 2017</xref>; <xref ref-type="bibr" rid="bib47">Packer et al., 2019</xref>). Scale bar indicates 14 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig1-figsupp1-v2.tif"/></fig></fig-group><p>In <italic>shn-1</italic> null mutants, PP rate and AP widths were significantly increased, AP amplitudes were decreased, resting membrane potential (RMP) was depolarized, while AP frequency and input resistance were unaltered (<xref ref-type="fig" rid="fig1">Figure 1D–I</xref>). Similar increases in AP widths and PP rate were observed in three, independently derived <italic>shn-1</italic> null mutants (<italic>nu712</italic>, <italic>nu652</italic>, and <italic>tm488</italic>) (<xref ref-type="table" rid="table1">Table 1</xref>). Single-cell RNA sequencing studies suggest that SHN-1 is expressed in muscles, neurons, glia, and epithelial cells (<xref ref-type="bibr" rid="bib10">Cao et al., 2017</xref>; <xref ref-type="bibr" rid="bib47">Packer et al., 2019</xref>), consistent with the broad expression of split GFP tagged <italic>shn-1(nu600</italic> GFP<sub>11</sub>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). To determine if SHN-1 functions in body muscles to control AP duration, we edited the endogenous <italic>shn-1</italic> locus to construct alleles that are either inactivated (<italic>nu697</italic>) or rescued (<italic>nu652</italic>) by the CRE recombinase (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Using these alleles, we found that AP widths and PP frequency were increased in <italic>shn-1</italic>(muscle Knockout, KO) and that this defect was eliminated in <italic>shn-1</italic>(muscle rescue) (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>). By contrast, <italic>shn-1</italic>(neuron KO) and <italic>shn-1</italic>(neuron rescue) had no effect on PP rate or AP widths (<xref ref-type="fig" rid="fig2">Figure 2C–D</xref>). Because CRE expression in muscles produced opposite changes in AP firing patterns in strains containing the <italic>shn-1 nu697</italic> and <italic>nu652</italic> alleles, these results are unlikely to be caused by toxicity associated with CRE expression (<xref ref-type="bibr" rid="bib61">Speed et al., 2019</xref>). The PP rate and AP width defects observed in <italic>shn-1</italic>(muscle KO) were not significantly different from those in <italic>shn-1(null</italic>) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Collectively, these results suggest that SHN-1 acts in body muscles to control AP duration.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>SHN-1 acts in muscles to control AP duration.</title><p>(<bold>A</bold>) A schematic of the <italic>shn-1</italic> locus is shown. Open boxes indicate UTRs, black boxes indicate coding regions. Recombination sites mediating CRE induced deletions (LoxP) and inversions (FLEX) are indicated. The <italic>shn-1(nu697</italic>) allele allows CRE-induced <italic>shn-1</italic> knockouts while <italic>shn-1(nu652</italic>) allows CRE-induced <italic>shn-1</italic> rescue. In <italic>shn-1(nu652</italic>), an exon containing in frame stop codons was inserted into the second intron (in the ‘OFF’ orientation). This stop exon is bounded by FLEX sites. (<bold>B</bold>) Representative traces of spontaneous muscle APs are shown in <italic>shn-1(nu697</italic>) with and without muscle CRE expression. Mean PP rate (<bold>C</bold>) and AP width (<bold>D</bold>) are compared in the indicated <italic>shn-1</italic> mutants without (-) and with CRE expression in muscles (<bold>m</bold>) or neurons (<bold>n</bold>). Sample sizes are as follows: <italic>shn-1(nu697</italic>) (17); <italic>shn-1(nu697</italic>) +muscle CRE (21); <italic>shn-1(nu697</italic>) +neuron CRE (15); <italic>shn-1(nu652</italic>) (18); <italic>shn-1(nu652</italic>) +muscle CRE (30); and <italic>shn-1(nu652</italic>) +neuron CRE (19). Values that differ significantly from wild-type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM. Representative traces for genotypes in panels C and D are shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Representative traces for recordings summarized in <xref ref-type="fig" rid="fig2">Figure 2C and D</xref>.</title><p>Representative traces of spontaneous muscle APs are shown for the indicated genotypes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Muscle AP defects in <italic>shn-1(null</italic>) and <italic>shn-1(muscle KO</italic>) are not significantly different.</title><p>Mean PP rate and AP width are compared in the indicated <italic>shn-1</italic> mutants. Sample sizes are as follows: <italic>shn-1(nu712</italic> null) (21); <italic>shn-1(nu697</italic>) +muscle CRE (21). Error bars indicate SEM. No significant differences were observed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig2-figsupp2-v2.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Comparison of <italic>shn-1</italic> null alleles.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Genotype:</th><th align="left" valign="bottom">PP rate (Hz):</th><th align="left" valign="bottom">AP width (ms):</th><th align="left" valign="bottom">AP Amp. (mV):</th><th align="left" valign="bottom">RMP (mV):</th></tr></thead><tbody><tr><td align="left" valign="bottom">WT</td><td align="char" char="plusmn" valign="bottom">0.01 ± 0.00</td><td align="char" char="plusmn" valign="bottom">26.73 ± 1.98</td><td align="char" char="plusmn" valign="bottom">40.42 ± 0.77</td><td align="char" char="plusmn" valign="bottom">–12.61 ± 0.96</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu712</italic>)</td><td align="char" char="plusmn" valign="bottom">0.04 ± 0.01**</td><td align="char" char="plusmn" valign="bottom">42.28 ± 4.17***</td><td align="char" char="plusmn" valign="bottom">37.63 ± 0.83*</td><td align="char" char="plusmn" valign="bottom">–8.33 ± 0.72**</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu652</italic>)</td><td align="char" char="plusmn" valign="bottom">0.05 ± 0.02***</td><td align="char" char="plusmn" valign="bottom">58.06 ± 5.27***</td><td align="char" char="plusmn" valign="bottom">34.78 ± 0.92***</td><td align="char" char="plusmn" valign="bottom">–7.19 ± 0.99***</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(tm488</italic>)</td><td align="char" char="plusmn" valign="bottom">0.05 ± 0.01***</td><td align="char" char="plusmn" valign="bottom">49.06 ± 7.07***</td><td align="char" char="plusmn" valign="bottom">41.36 ± 1.64</td><td align="char" char="plusmn" valign="bottom">–12.06 ± 1.54</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn><p>Mean, SEM, and significant differences from WT controls are indicated (*, <italic>P</italic> &lt; 0.05; **, <italic>P</italic> &lt; 0.01; ***, <italic>P</italic> &lt; 0.001).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>SHN-1 binding to EGL-19 promotes AP repolarization</title><p>Because SHN-1 has multiple binding partners, we sought to confirm that prolonged APs result from decreased SHN-1 binding to EGL-19. To address this question, we recorded APs in strains containing mutations that disrupt this interaction (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). PP frequency was significantly increased by a deletion removing the EGL-19 carboxy-terminal PDZ ligand [<italic>egl-19(nu496</italic> ΔVTTL)] (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). AP widths were significantly increased by a deletion removing the SHN-1 PDZ domain [<italic>shn-1(nu542</italic> ΔPDZ)] and by the <italic>egl-19(nu496</italic> ΔVTTL) mutation (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Furthermore, the <italic>shn-1(nu712</italic> null) and <italic>egl-19(nu496</italic> ΔVTTL) mutations did not have additive effects on PP rate and AP widths in double mutants (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Taken together, these results support the idea that SHN-1 binding to EGL-19/CaV1 accelerates AP repolarization.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Mutations disrupting SHN-1 binding to EGL-19 increase AP duration.</title><p>(<bold>A</bold>) A schematic illustrating the binding interaction between EGL-19’s c-terminus and SHN-1’s PDZ domain is shown. (<bold>B–C</bold>) Mean PP rate and AP width are compared in the indicated genotypes. Representative traces are shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Mutations deleting the SHN-1 PDZ domain (<italic>nu542</italic> ΔPDZ) or those deleting EGL-19’s c-terminal PDZ ligand (<italic>nu496</italic> ΔVTTL) were edited into the endogenous genes using CRISPR. These mutations significantly increased AP width, compared to WT controls. Sample sizes are as follows: WT (41), <italic>shn-1(nu542</italic>) (22), and <italic>egl-19(nu496</italic>) (22). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Representative traces for recordings summarized in <xref ref-type="fig" rid="fig3">Figure 3B and C</xref>.</title><p>Representative traces of spontaneous muscle APs are shown for the indicated genotypes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Muscle AP defects in <italic>shn-1(null</italic>) and <italic>shn-1(null); egl-19</italic>(ΔVTTL) double mutants are not significantly different.</title><p>Mean PP rate and AP width are compared in the indicated genotypes. Sample sizes are as follows: <italic>shn-1(nu712</italic> null) (21); <italic>shn-1(nu712); egl-19</italic>(ΔVTTL) (15). Error bars indicate SEM. No significant differences were observed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig3-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>AP repolarization is controlled by SHK-1 KCNA and SLO-1/2 BK channels</title><p>To investigate how SHN-1 controls AP duration, we first asked which potassium channels promote repolarization following APs. Prior studies showed that voltage-activated potassium currents in body muscles are mediated by SHK-1/KCNA and BK channels (<xref ref-type="bibr" rid="bib22">Gao and Zhen, 2011</xref>; <xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref>). SHK-1 channel function can be assessed in recordings using an internal solution containing low chloride levels (hereafter Ik<sub>loCl</sub>). Ik<sub>loCl</sub> was nearly eliminated in <italic>shk-1</italic> single mutants (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). BK channel function can be assayed in recordings utilizing internal solutions with high chloride levels (hereafter Ik<sub>hiCl</sub>), which activates SLO-2 channels (<xref ref-type="bibr" rid="bib73">Yuan et al., 2000</xref>). Ik<sub>hiCl</sub> was ~50% reduced in single mutants lacking either SLO-2 or SHK-1 and was eliminated in <italic>slo-2; shk-1</italic> double mutants (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref>). These results suggest that SHK-1/KCNA and SLO-2/BK are the primary channels promoting AP repolarization. Consistent with this idea, AP duration was significantly increased in mutants lacking SHK-1/KCNA (<xref ref-type="fig" rid="fig4">Figure 4E–F</xref>), as previously reported (<xref ref-type="bibr" rid="bib22">Gao and Zhen, 2011</xref>; <xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>AP repolarization is mediated by SHK-1 and SLO channels.</title><p>(<bold>A–D</bold>) Muscle voltage activated potassium currents are mediated by SHK-1 and SLO-2. Voltage activated potassium currents were recorded using pipette solutions containing low (Ik<sub>loCl</sub>, <bold>A–B</bold>) and high (Ik<sub>hiCl</sub>, <bold>C–D</bold>) chloride concentrations. Representative traces (<bold>A,C</bold>) and mean current density (<bold>B,D</bold>) at +30 mV are shown. Ik<sub>loCl</sub> is mediated by SHK-1 whereas SHK-1 and SLO-2 equally contribute to Ik<sub>hiCl</sub>. (<bold>E–F</bold>) AP durations are significantly increased in mutants lacking SHK-1, SLO-1, and SLO-2 channels. The AP widths observed in <italic>slo-1; slo-2</italic> double mutants were not significantly different from those found in <italic>slo-2</italic> single mutants. Representative traces (E and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) and mean AP widths (<bold>F</bold>) are shown. Alleles used in this figure were: <italic>shk-1(ok1581</italic>), <italic>slo-1(js379</italic>), and <italic>slo-2(nf100</italic>). Sample sizes are as follows: in panel B, WT (5), <italic>slo-2</italic> (7), and <italic>shk-1</italic> (5); in panel D, WT (10), <italic>slo-2</italic> (5), <italic>shk-1</italic> (5), <italic>shk-1;slo-2</italic> (6); in panel F, WT (16), <italic>slo-1</italic> (13), <italic>slo-2</italic> (14), <italic>slo-1; slo-2</italic> (8), <italic>shk-1</italic> (7). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Representative traces for recordings summarized in <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title><p>Representative traces of spontaneous muscle APs are shown for the indicated genotypes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Contradictory results have been reported for AP firing patterns in <italic>slo-1</italic> and <italic>slo-2</italic> BK mutants (<xref ref-type="bibr" rid="bib22">Gao and Zhen, 2011</xref>; <xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref>). These studies used intracellular solutions that alter BK channel function. In (<xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref>), an intracellular solution containing high chloride levels was used, thereby exaggerating SLO-2’s contribution to AP repolarization (<xref ref-type="bibr" rid="bib73">Yuan et al., 2000</xref>). In (<xref ref-type="bibr" rid="bib22">Gao and Zhen, 2011</xref>), an intracellular solution containing a fast calcium chelator (BAPTA) was used, which inhibits BK activation thereby minimizing their impact on APs. We re-investigated the effect of SLO channels on APs using intracellular solutions with low chloride and a slow calcium chelator (EGTA), finding that AP durations were increased to a similar extent in <italic>slo-1</italic> and <italic>slo-2</italic> single mutants (<xref ref-type="fig" rid="fig4">Figure 4E–F</xref>). Taken together, these results confirm that SHK-1/KCNA and SLO/BK are the primary channels promoting AP repolarization in body muscles.</p></sec><sec id="s2-4"><title>SLO-1 and SLO-2 function together to promote AP repolarization</title><p>SLO-1 and SLO-2 subunits are co-expressed in muscles and could potentially co-assemble to form heteromeric channels. To determine if channels containing both SLO-1 and SLO-2 regulate AP repolarization, we analyzed AP widths in <italic>slo-1; slo-2</italic> double mutants. AP widths in <italic>slo-1; slo-2</italic> double mutants were not significantly different from those found in the single mutants (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Because <italic>slo-1</italic> and <italic>slo-2</italic> mutations did not have additive effects on AP widths, these results support the idea that heteromeric SLO-1/2 channels mediate rapid repolarization of muscle APs.</p><p>We did several experiments to further test the idea that SLO-1 and SLO-2 function together in heteromeric channels. First, we recorded voltage-activated potassium current in body muscles and found that Ik<sub>hiCl</sub> was modestly reduced in <italic>slo-1</italic> mutants, was dramatically reduced in <italic>slo-2</italic> mutants, and was not further reduced in <italic>slo-1; slo-2</italic> double mutants (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>). These results suggest that Ik<sub>hiCl</sub> is mediated by heteromeric channels (containing both SLO-1 and SLO-2 subunits) and by SLO-2 homomers.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>SLO-2 and SLO-1 function together in heteromeric channels.</title><p>(<bold>A–B</bold>) Ik<sub>hiCl</sub> was significantly decreased in <italic>slo-1(js379</italic>) and <italic>slo-2(nf100</italic>) single mutants but was not further decreased in <italic>slo-1; slo-2</italic> double mutants. Representative traces (<bold>A</bold>) and mean current density (<bold>B</bold>) at +30 mV are shown. Sample sizes for panel B: WT (15), <italic>slo-1</italic> (9), <italic>slo-2</italic> (12), <italic>slo-1;slo-2</italic> (6). (<bold>C–F</bold>) Expression of split GFP tagged SLO-2 (<bold>C–D</bold>) and SLO-1 (<bold>E–F</bold>) was analyzed in body muscles. CRISPR alleles were constructed adding 7 copies of GFP<sub>11</sub> to the endogenous <italic>slo-1</italic> and <italic>slo-2</italic> genes (<xref ref-type="table" rid="table2">Table 2</xref>) and fluorescence was reconstituted by expressing GFP<sub>1-10</sub> in body muscles. Controls showing that the GFP<sub>11</sub> tags had no effect on AP width, RMP, and potassium currents are shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. Representative images (<bold>C and E</bold>) and mean puncta intensity (<bold>D and F</bold>) are shown. SLO-2 puncta intensity was significantly decreased in <italic>slo-1(js379</italic>) mutants. SLO-1 puncta intensity was unaltered in <italic>slo-2(nf100</italic>) mutants. Sample sizes are as follows: in panel D, WT (38) and <italic>slo-1</italic> (23); in panel F, WT (34) and <italic>slo-2</italic> (19). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM. Scale bar indicates 4 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Analysis of GFP<sub>11</sub> tagged <italic>slo-1</italic> and <italic>slo-2</italic> alleles.</title><p>APs and potassium currents were analyzed in strains containing <italic>slo-1(nu678</italic> GFP<sub>11</sub>) and <italic>slo-2(nu725</italic> GFP<sub>11</sub>) together with the muscle&gt;GFP<sub>1-10</sub> transgene. Mean AP width (<bold>A</bold>), RMP (<bold>B</bold>), and Ik<sub>hiCl</sub> current density (<bold>C</bold>) were not significantly different from WT controls. Sample sizes are as follows: in panels A and B, WT (25), <italic>slo-1(nu678</italic>) (15), and <italic>slo-2(nu725</italic>) (13); in panel C, WT (10), <italic>slo-1(nu678</italic>) (12), and <italic>slo-2(nu725</italic>) (6). Error bars indicate SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig5-figsupp1-v2.tif"/></fig></fig-group><p>As a final test of this idea, we asked if subcellular localization of SLO-1 and SLO-2 subunits requires expression of both subunits. For this analysis, endogenous SLO-1 and SLO-2 subunits were labeled with split GFP. Using CRISPR, we introduced the eleventh β-strand of GFP (GFP<sub>11</sub>) into the endogenous <italic>slo-1</italic> and <italic>slo-2</italic> genes and visualized their expression by expressing GFP<sub>1-10</sub> in body muscles. Strains containing the GFP<sub>11</sub> tagged alleles exhibited wild-type AP widths, RMP, and Ik<sub>hiCl</sub> currents, indicating that the tag did not interfere with SLO channel function (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Using these alleles, we find that SLO-2 puncta intensity was significantly reduced in <italic>slo-1</italic> null mutants, indicating that channels containing SLO-2 subunits require SLO-1 for their trafficking (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). By contrast, SLO-1 puncta intensity was unaffected in <italic>slo-2</italic> mutants, suggesting that BK channels lacking SLO-2 were trafficked normally (<xref ref-type="fig" rid="fig5">Figure 5E–F</xref>). Collectively, these results suggest that rapid muscle repolarization following APs is mediated by SLO-1/2 heteromeric channels and by SLO-2 homomers. Two prior studies also suggested that SLO subunits form heteromeric channels when heterologously expressed in <italic>Xenopus</italic> oocytes. SLO-1 currents were inhibited by a dominant-negative SLO-2 construct (<xref ref-type="bibr" rid="bib73">Yuan et al., 2000</xref>). Similarly, mammalian SLO2 subunits (KCNT1 and 2) co-assemble to form heteromeric channels (<xref ref-type="bibr" rid="bib11">Chen et al., 2009</xref>). Our results suggest that endogenously expressed SLO subunits also form heteromeric channels in native tissues.</p></sec><sec id="s2-5"><title>SHN-1 controls AP duration through BK channels</title><p>SHN-1’s impact on AP duration could be mediated by changes in either SHK-1 or SLO channels. To determine if SHN-1 acts through SLO channels, we asked if <italic>slo-2</italic> mutations block SHN-1’s effects on AP widths. Consistent with this idea, AP widths in <italic>slo-2</italic> single mutants were not significantly different from those in <italic>slo-2</italic> double mutants containing <italic>shn-1(nu712</italic> null), <italic>shn-1(nu542</italic> ΔPDZ), or <italic>egl-19(nu496</italic> ΔVTTL) mutations (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). These results suggest that SHN-1 controls AP duration by regulating SLO-2 channels.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>SHN-1 controls AP width by regulating SLO-2.</title><p>(<bold>A</bold>) A <italic>slo-2</italic> null mutation blocks the effect of SHN-1 on AP width. Mean AP widths in <italic>slo-2(nf100</italic>) double mutants containing <italic>shn-1(nu712</italic> null)<italic>, shn-1(nu542</italic> ΔPDZ)<italic>,</italic> and <italic>egl-19(nu496</italic> ΔVTTL) mutations were not significantly different from those in <italic>slo-2</italic> single mutants. Representative traces are shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>. Sample sizes: WT (41), <italic>slo-2</italic> (14), <italic>slo-2;shn-1</italic> (8), <italic>slo-2</italic>;ΔPDZ (8), and <italic>slo-2</italic>;ΔVTTL (10). (<bold>B–C</bold>) Ik<sub>loCl</sub> currents were unaltered in <italic>shn-1(nu712</italic> null) mutants. Representative traces (<bold>B</bold>) and mean current density at +30 mV (<bold>C</bold>) are shown. Sample sizes: WT (9) and <italic>shn-1</italic> (10). These results show that SHK-1 channel function was unaffected in <italic>shn-1</italic> mutants. (<bold>D–E</bold>) Ik<sub>hiCl</sub> currents were significantly smaller in <italic>shn-1(nu712</italic> null) and <italic>shn-1(nu542</italic> ΔPDZ) mutants but were unaffected in <italic>egl-19(nu496</italic> ΔVTTL) mutants. The effect of <italic>shn-1</italic> mutations on Ik<sub>hiCl</sub> was eliminated in double mutants lacking SLO-2, indicating that the SHN-1 sensitive potassium current is mediated by SLO-2. Ik<sub>hiCl</sub> currents were recorded from adult body wall muscles of the indicated genotypes at holding potentials of –60 to +60 mV. Representative traces (D and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>) and mean current density at +30 mV (<bold>E</bold>) are shown. Sample sizes in panel E: WT (12), <italic>shn-1</italic> (11), <italic>slo-2</italic> (12), ΔPDZ (9), ΔVTTL (8), <italic>slo-2;shn-1</italic> (6), <italic>slo-2</italic>;ΔPDZ (8), and <italic>slo-2</italic>;ΔVTTL (7). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Representative traces for recordings summarized in <xref ref-type="fig" rid="fig6">Figure 6A and E</xref>.</title><p>Representative traces of spontaneous muscle APs (<bold>A</bold>) and Ik<sub>hiCl</sub> currents at +30 mV (<bold>B</bold>) are shown for the indicated genotypes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig6-figsupp1-v2.tif"/></fig></fig-group><p>To confirm that SHN-1 regulates SLO-2 channels, we analyzed potassium currents in <italic>shn-1</italic> mutants. A <italic>shn-1</italic> null mutation had no effect on Ik<sub>loCl</sub> currents, indicating that SHK-1 function was unaffected (<xref ref-type="fig" rid="fig6">Figure 6B–C</xref>). By contrast, Ik<sub>hiCl</sub> was ~30% reduced in <italic>shn-1</italic> null mutants, ~ 50% reduced in <italic>slo-2</italic> mutants, and was not further reduced in <italic>shn-1; slo-2</italic> double mutants (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>). Lack of additivity in <italic>shn-1; slo-2</italic> double mutants suggests that the SHN-1-sensitive potassium current was mediated by SLO-2. A similar decrease in Ik<sub>hiCl</sub> current was observed in <italic>shn-1(nu542</italic> ΔPDZ) mutants (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Ik<sub>hiCl</sub> current was unaltered in <italic>egl-19(nu496</italic> ΔVTTL) mutants, implying that SHN-1 binding to EGL-19’s carboxy terminus is not required for SLO-2 current (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Thus, <italic>shn-1</italic> inactivation decreased SLO-1/2 BK current but had little or no effect on SHK-1 KCNA current; consequently, SHN-1 regulates AP widths by promoting activation of SLO-1/2 channels.</p></sec><sec id="s2-6"><title>SHN-1 promotes microdomain coupling of SLO-2 with EGL-19/CaV1 channels</title><p>BK channels bind calcium with affinities ranging from 1 to 10 μM (<xref ref-type="bibr" rid="bib12">Contreras et al., 2013</xref>). As a result of this calcium dependence, BK channels have very low open probability at resting cytoplasmic calcium levels (~100 nM) and efficient BK activation typically requires close spatial coupling to calcium channels (<xref ref-type="bibr" rid="bib5">Barrett et al., 1982</xref>). We next asked if body muscle BK channels are functionally coupled to EGL-19/CaV1 channels. Consistent with this idea, Ik<sub>hiCl</sub> current was significantly decreased by nemadipine, an EGL-19/CaV1 antagonist (<xref ref-type="fig" rid="fig7">Figure 7A–B</xref>; <xref ref-type="bibr" rid="bib37">Kwok et al., 2008</xref>). The inhibitory effect of nemadipine on Ik<sub>hiCl</sub> was eliminated in <italic>slo-2</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7A–B</xref>), suggesting that the nemadipine-sensitive potassium current was mediated by SLO-2.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>SHN-1 promotes EGL-19 to SLO-2 microdomain coupling.</title><p>(<bold>A–B</bold>) SLO-2 activation is functionally coupled to EGL-19. Ik<sub>hiCl</sub> was significantly reduced by nemadipine (an EGL-19 antagonist). This inhibitory effect of nemadipine on Ik<sub>hiCl</sub> was eliminated in <italic>slo-2(nf100</italic>) mutants, indicating that the nemadipine sensitive current is mediated by SLO-2. Ik<sub>hiCl</sub> currents were recorded from adult body wall muscles of the indicated genotypes at holding potentials of –60 to +60 mV. Representative Ik<sub>hiCl</sub> traces (<bold>A</bold>) and mean current density as a function of membrane potential (<bold>B</bold>) are shown. (<bold>C</bold>) SLO-2 activation requires microdomain coupling to EGL-19. Ik<sub>hiCl</sub> currents recorded in BAPTA are significantly smaller than those in EGTA. The inhibitory effect of BAPTA was reduced in <italic>shn-1(nu712</italic> null) mutants and was eliminated in <italic>slo-2(nf100</italic>) mutants, indicating that the BAPTA sensitive current is mediated by SLO-2. The ratio of Ik<sub>hiCl</sub> current density at +30 mV recorded in BAPTA to the mean current density recorded in EGTA is plotted for the indicated genotypes. Representative traces are shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>. Sample sizes for panel C: WT (8), <italic>slo-2</italic> (8), and <italic>shn-1</italic> (10). (<bold>D–E</bold>) AP repolarization is mediated by microdomain activation of SLO-2. AP widths recorded in solutions containing BAPTA are wider than those recorded in EGTA. The effect of BAPTA on AP widths was reduced in <italic>shn-1(nu712</italic> null) mutants and was eliminated in <italic>slo-2(nf100</italic>) mutants, indicating that BAPTA’s effect is mediated by SLO-2. Representative traces of WT muscle APs recorded in EGTA and BAPTA are shown (<bold>D</bold>). The ratio of AP widths recorded in BAPTA to the mean AP widths recorded in EGTA is plotted for the indicated genotypes (<bold>E</bold>). Representative traces for panel E are shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>. Sample sizes for panel E: WT (8), <italic>slo-2</italic> (11), and <italic>shn-1</italic> (10). (<bold>F–H</bold>) SLO-2(nu725 GFP<sub>11</sub>) is partially co-localized with EGL-19(nu722 Cherry<sub>11</sub>) in body muscles. GFP<sub>11</sub> and Cherry<sub>11</sub> fluorescence were reconstituted by expressing GFP<sub>1-10</sub> and Cherry<sub>1-10</sub> in body muscles. SLO-2 puncta intensity was significantly reduced in <italic>shn-1(nu712</italic> null) mutants but was unaffected in <italic>shn-1(nu542</italic> ΔPDZ) and <italic>egl-19(nu496</italic> ΔVTTL) mutants. Representative images (<bold>F</bold>) and mean puncta intensity for SLO-2 (<bold>G</bold>) and EGL-19 (<bold>H</bold>) are shown. Sample sizes for panel G: <italic>slo-2</italic>(GFP<sub>11</sub>) single mutants (38), and double mutants containing the <italic>shn-1</italic> (35), ΔPDZ (39), and ΔVTTL (18) mutations. Sample sizes for panel H: <italic>egl-19</italic>(Cherry<sub>11</sub>) single mutants (34) and <italic>shn-1; egl-19</italic>(Cherry<sub>11</sub>) double mutants (31). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM. Scale bar indicates 4 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Representative traces for recordings summarized in <xref ref-type="fig" rid="fig7">Figure 7C and E</xref>.</title><p>Representative traces of Ik<sub>hiCl</sub> currents at +30 mV (<bold>A</bold>) and spontaneous muscle APs (<bold>B</bold>) are shown for the indicated genotypes and recording conditions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>SLO-1 and UNC-68/RYR puncta intensity is unaltered in <italic>shn-1</italic> mutant muscles.</title><p>SLO-1(nu678 GFP<sub>11</sub>) and UNC-68(nu664 GFP<sub>11</sub>) puncta intensity in body muscles is compared in WT and <italic>shn-1</italic>(null) mutants. GFP<sub>11</sub> fluorescence was reconstituted by expressing GFP<sub>1-10</sub> in body muscles. Representative images (<bold>A and C</bold>) and mean puncta intensity (<bold>B and D</bold>) are shown. Sample sizes: <italic>slo-1</italic>(GFP<sub>11</sub>) single mutants (23); <italic>shn-1(nu712</italic> null)<italic>;slo-1</italic>(GFP<sub>11</sub>) double mutants (17); <italic>unc-68</italic>(GFP<sub>11</sub>) single mutants (20); and <italic>shn-1(tm488</italic> null)<italic>;unc-68</italic>(GFP<sub>11</sub>) double mutants (20). No significant differences were observed. Error bars indicate SEM. Scale bars indicate 4 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig7-figsupp2-v2.tif"/></fig></fig-group><p>Is EGL-19 coupling to SLO-2 mediated by microdomain signaling? To test this idea, we compared Ik<sub>hiCl</sub> and AP widths recorded with intracellular solutions containing fast (BAPTA) and slow (EGTA) calcium chelators (<xref ref-type="fig" rid="fig7">Figure 7C–E</xref>). We found that Ik<sub>hiCl</sub> recorded with BAPTA was significantly smaller than that recorded with EGTA (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Similarly, AP widths recorded with BAPTA were significantly longer than those recorded with EGTA (<xref ref-type="fig" rid="fig7">Figure 7D–E</xref>). The effect of BAPTA on Ik<sub>hiCl</sub> and AP widths was eliminated in <italic>slo-2</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7C and E</xref>), suggesting that the BAPTA sensitive potassium current is mediated by SLO-2. BAPTA’s effect on Ik<sub>hiCl</sub> and AP widths was reduced but not eliminated in <italic>shn-1</italic> mutants (<xref ref-type="fig" rid="fig7">Figure 7C and E</xref>), consistent with the partial loss of SLO-2 current in these mutants (<xref ref-type="fig" rid="fig6">Figure 6D–E</xref>). Taken together, these results suggest that SHN-1 promotes SLO-2 microdomain coupling to EGL-19/CaV1.</p><p>If BK channels are functionally coupled to EGL-19/CaV1, these channels should be co-localized. Endogenous SLO-2 channels (tagged with GFP<sub>11</sub>) were distributed in a punctate pattern on the muscle surface. A subset of the SLO-2 puncta co-localized with EGL-19/CaV1 channels (tagged with Cherry<sub>11</sub>), suggesting that EGL-19 nanocomplexes are heterogeneous (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). SLO-2 puncta intensity was significantly reduced in <italic>shn-1</italic> null mutants (<xref ref-type="fig" rid="fig7">Figure 7F–G</xref>), consistent with the decreased SLO-2 current observed in these mutants. By contrast, SLO-2 puncta intensity was unaltered in <italic>shn-1</italic>(<italic>nu542</italic> ΔPDZ) and <italic>egl-19</italic>(<italic>nu496</italic> ΔVTTL) mutants (<xref ref-type="fig" rid="fig7">Figure 7G</xref>), in which SHN-1 binding to EGL-19’s c-terminus is disrupted (<xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>). Next, we asked if inactivating SHN-1 alters the localization of other muscle ion channels. SLO-1 puncta intensity was unaltered in <italic>shn-1</italic> null mutants, indicating that BK channels lacking SLO-2 were trafficked normally (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A-B</xref>). In body muscles, EGL-19/CaV1 channels are extensively co-localized with calcium channels in the endoplasmic reticulum (ER), UNC-68/Ryanodine Receptors (RYR) (<xref ref-type="bibr" rid="bib53">Piggott et al., 2021</xref>). However, the puncta intensity of endogenous EGL-19(Cherry<sub>11</sub>) and UNC-68(GFP<sub>11</sub>)/RYR in body muscles were unaltered in <italic>shn-1</italic>(null) mutants (<xref ref-type="fig" rid="fig7">Figure 7H</xref> and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2C-D</xref>), suggesting that SHN-1 does not broadly regulate co-localization of ion channels at ER-plasma membrane junctional contacts. Collectively, these results suggest that SHN-1 stabilizes SLO-2 clusters in the plasma membrane and promotes activation of heteromeric SLO-1/2 channels by nearby calcium channels.</p></sec><sec id="s2-7"><title>EGL-19 to SLO-2 coupling is sensitive to <italic>shn-1</italic> gene dose</title><p>Deletion and duplication of human shank genes are both associated with ASD, schizophrenia, and mania (<xref ref-type="bibr" rid="bib7">Bonaglia et al., 2006</xref>; <xref ref-type="bibr" rid="bib15">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="bib17">Failla et al., 2007</xref>; <xref ref-type="bibr" rid="bib23">Gauthier et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Han et al., 2013</xref>). These results suggest that Shank phenotypes relevant to psychiatric disorders should exhibit a similar sensitivity to Shank copy number. For this reason, we analyzed the effect of <italic>shn-1</italic> gene dosage on Ik<sub>hiCl</sub> and AP duration (<xref ref-type="fig" rid="fig8">Figure 8</xref>). We analyzed animals with 1 (<italic>nu712/+</italic> heterozygotes), 2 (WT), and 4 (WT +2 single copy <italic>shn-1</italic> transgenes) copies of <italic>shn-1</italic>. Compared to wild-type controls, AP duration was significantly increased (<xref ref-type="fig" rid="fig8">Figure 8A and B</xref>) while muscle Ik<sub>hiCl</sub> was significantly decreased (<xref ref-type="fig" rid="fig8">Figure 8C and D</xref>) in animals containing 1 and 4 copies of <italic>shn-1</italic>. Thus, increased and decreased <italic>shn-1</italic> gene dosage produced similar defects in AP duration and SLO-2 current.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>AP width and SLO-2 current are sensitive to <italic>shn-1</italic> gene dosage.</title><p>The effect of <italic>shn-1</italic> gene dosage on AP widths (<bold>A–B</bold>) and Ik<sub>hiCl</sub> current (<bold>C–D</bold>) was analyzed. Ik<sub>hiCl</sub> was significantly decreased while AP duration was significantly increased in animals containing 1 and 4 copies of <italic>shn-1</italic> compared to WT controls (i.e. 2 copies). The following genotypes were analyzed: 1 copy of <italic>shn-1</italic> [<italic>shn-1(nu712</italic>)/ + heterozygotes], 2 copies of <italic>shn-1</italic> (WT) and 4 copies of <italic>shn-1</italic> (<italic>nuSi26</italic> homozygotes in wild-type). Ik<sub>hiCl</sub> currents were recorded from adult body wall muscles of the indicated genotypes at holding potentials of –60 to +60 mV. Representative traces (<bold>A,C</bold>), mean AP width (<bold>B</bold>), and mean Ik<sub>hiCl</sub> current density at +30 mV (<bold>D</bold>) are shown. Sample sizes: for panel B, 1 copy (8), 2 copies (21), and four copies (15); for panel D, 1 copy (8), 2 copies (15), and four copies (7). Significant differences are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig8-v2.tif"/></fig></sec><sec id="s2-8"><title>SHN-1 regulates BK channel activation in motor neurons</title><p>Thus far, our results suggest that SHN-1 promotes EGL-19 to SLO-2 coupling in muscles. We next asked if SHN-1 also promotes coupling in motor neurons. To test this idea, we analyzed Ik<sub>hiCl</sub> in cholinergic motor neurons and found that it was significantly reduced in <italic>shn-1</italic> null mutants (<xref ref-type="fig" rid="fig9">Figure 9A–C</xref>). The <italic>slo-2</italic> and <italic>shn-1</italic> mutations did not have additive effects on Ik<sub>hiCl</sub> in double mutants, suggesting that the <italic>shn-1</italic> mutation selectively decreases SLO-2 current in motor neurons (<xref ref-type="fig" rid="fig9">Figure 9A–C</xref>). Consistent with decreased SLO-2 currents, we observed a corresponding decrease in axonal SLO-2(<italic>nu725</italic> GFP<sub>11</sub>) puncta fluorescence in <italic>shn-1</italic> mutant motor neurons (<xref ref-type="fig" rid="fig9">Figure 9D–E</xref>). Thus, our results suggest that SHN-1 promotes EGL-19/CaV1 to SLO-2 coupling in both body muscles and cholinergic motor neurons.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>SHN-1 controls SLO-2 currents in motor neurons.</title><p>(<bold>A–B</bold>) Ik<sub>hiCl</sub> currents in cholinergic motor neurons were significantly decreased in <italic>shn-1(nu712</italic> null) mutants. Ik<sub>hiCl</sub> currents were recorded from adult cholinergic motor neurons of the indicated genotypes at holding potentials of –60 to +60 mV. Representative traces (<bold>A</bold>), mean current density as a function of membrane potential (<bold>B</bold>), and mean current density at +30 mV (<bold>C</bold>) are shown. Sample sizes for panels B and C: WT (12), <italic>shn-1</italic> (10), <italic>slo-2</italic> (9), and <italic>shn-1; slo-2</italic> (9). (<bold>D–E</bold>) SLO-2 puncta intensity in motor neuron axons was significantly decreased in <italic>shn-1(nu712</italic> null) mutants. Representative images of SLO-2(<italic>nu725</italic> GFP<sub>11</sub>) and a synaptic vesicle marker [UNC-57/Endophilin(mCherry)] in dorsal cord axons of DA/DB motor neurons are shown (<bold>D</bold>). GFP<sub>11</sub> fluorescence was reconstituted with GFP<sub>1-10</sub> expressed in DA/DB motor neurons (using the <italic>unc-129</italic> promoter). Mean SLO-2 puncta intensity in axons is plotted (<bold>E</bold>). Sample sizes for panel E: WT (21) and <italic>shn-1</italic> (25). Values that differ significantly from wild type controls are indicated (ns, not significant; *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001). Error bars indicate SEM. Scale bar indicates 2 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-75140-fig9-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our results lead to six principal conclusions. First, we show that SHN-1 acts cell autonomously in muscles to promote rapid repolarization of APs. Second, heteromeric BK channels containing both SLO-1 and SLO-2 subunits promote AP repolarization. Third, SHN-1 limits AP duration by promoting BK channel activation. Fourth, <italic>shn-1</italic> mutants have decreased SLO-2 channel clustering and decreased SLO-2 currents. Fifth, increased and decreased SHN-1 gene dosage produce similar defects in AP durations and SLO-2 currents. And sixth, SHN-1 also promotes SLO-2 activation in motor neurons. Below we discuss the significance of these findings.</p><sec id="s3-1"><title>Shank as a regulator of ion channel density</title><p>Several recent studies suggest that an important function of Shank proteins is to regulate ion channel density and localization. Mutations inactivating Shank have been shown to decrease AMPA and NMDA receptor abundance and post-synaptic currents (<xref ref-type="bibr" rid="bib48">Peça et al., 2011</xref>; <xref ref-type="bibr" rid="bib70">Won et al., 2012</xref>), HCN channels (<xref ref-type="bibr" rid="bib72">Yi et al., 2016</xref>; <xref ref-type="bibr" rid="bib76">Zhu et al., 2018</xref>), TRPV channels (<xref ref-type="bibr" rid="bib29">Han et al., 2016</xref>), and voltage-activated CaV1 calcium channels (<xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2017</xref>). Here, we show that Shank also regulates BK channel densities in <italic>C. elegans</italic> muscles and motor neurons. Collectively, these studies suggest that Shank proteins have the capacity to control localization of many ion channels, thereby shaping neuron and muscle excitability.</p><p>Shank regulation of BK channels could have broad effects on neuron and muscle function. In neurons, BK channels are functionally coupled to CaV channels in the soma and dendrites, thereby regulating AP firing patterns and somatodendritic calcium transients (<xref ref-type="bibr" rid="bib25">Golding et al., 1999</xref>; <xref ref-type="bibr" rid="bib64">Storm, 1987</xref>). In pre-synaptic terminals, BK channels limit the duration of calcium influx during APs, thereby decreasing neurotransmitter release (<xref ref-type="bibr" rid="bib27">Griguoli et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Yazejian et al., 2000</xref>). In muscles, BK channels regulate AP firing patterns, calcium influx during APs, and muscle contraction (<xref ref-type="bibr" rid="bib14">Dopico et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Latorre et al., 2017</xref>). Thus, Shank mutations could broadly alter neuron and muscle function via changes in CaV-BK coupling. It will be very interesting to determine if this new function for Shank is conserved in other animals, including humans.</p></sec><sec id="s3-2"><title>SHN-1 promotes microdomain coupling of CaV1 and BK channels</title><p>BK channel activation requires tight coupling to CaV channels (<xref ref-type="bibr" rid="bib6">Berkefeld et al., 2006</xref>). Our results suggest that SHN-1 promotes CaV1-BK microdomain coupling. APs were prolonged in <italic>shn-1</italic> (null), <italic>shn-1</italic>(ΔPDZ), and <italic>egl-19</italic>(ΔVTTL) mutants and in all cases these defects were eliminated in double mutants lacking SLO-2. Interestingly, although all impair SLO-2 mediated AP repolarization, these mutations had distinct effects on SLO-2 channels. SLO-2 currents were reduced in <italic>shn-1</italic> (null) and <italic>shn-1</italic>(ΔPDZ) mutants but were unaffected in <italic>egl-19</italic>(ΔVTTL) mutants. SLO-2 puncta intensity was decreased in <italic>shn-1</italic>(null) mutants but was unaffected in <italic>shn-1</italic>(ΔPDZ) and <italic>egl-19</italic>(ΔVTTL) mutants. These differences suggest that these mutants comprise an allelic series for EGL-19 to SLO-2 coupling defects in the following hierarchy <italic>shn-1</italic> (null) &gt;<italic>shn-1</italic>(ΔPDZ) &gt; <italic>egl-19</italic>(ΔVTTL) mutants. Based on these results, we propose that multiple protein interactions progressively tighten CaV-BK coupling. Specifically, we propose that: (1) multiple SHN-1 domains act together to promote SLO-2 coupling to EGL-19, accounting for the distinct phenotypes observed in <italic>shn-1</italic>(null) and <italic>shn-1</italic>(ΔPDZ) mutants; (2) SHN-1 promotes formation (or stability) of SLO-2 clusters in the plasma membrane, as indicated by decreased SLO-2 puncta intensity in <italic>shn-1</italic>(null) mutants; (3) beyond this trafficking function, SHN-1’s PDZ domain tightens SLO-2 coupling to nearby calcium channels, accounting for the smaller SLO-2 current but unaltered SLO-2 puncta intensity in <italic>shn-1</italic>(ΔPDZ) mutants; (4) SHN-1 PDZ binding to EGL-19’s c-terminus promotes rapid SLO-2 activation during APs, accounting for the increased AP width but unaltered SLO-2 current and puncta intensity in <italic>egl-19</italic>(ΔVTTL) mutants; and (5) SHN-1’s PDZ must bind multiple proteins (not just EGL-19) to promote SLO-2 activation, accounting for the different phenotypes found in in <italic>shn-1</italic>(ΔPDZ) and <italic>egl-19</italic>(ΔVTTL) mutants. Multivalent interactions between scaffolds and their client proteins may represent a general mechanism for promoting microdomain signaling. Although SHN-1 binds EGL-19, SHN-1 may not directly link EGL-19 to SLO/BK channels. Instead, SHN-1 may link EGL-19 to other proteins required for SLO channel localization, for example components of the dystrophin complex (<xref ref-type="bibr" rid="bib35">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bib57">Sancar et al., 2011</xref>).</p></sec><sec id="s3-3"><title>Implications for understanding neurodevelopmental disorders</title><p>Several studies suggest that Shank3 deletions and duplications are both linked to ASD and schizophrenia, suggesting that opposite changes in Shank3 levels produce similar or overlapping psychiatric phenotypes (<xref ref-type="bibr" rid="bib7">Bonaglia et al., 2006</xref>; <xref ref-type="bibr" rid="bib15">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="bib17">Failla et al., 2007</xref>; <xref ref-type="bibr" rid="bib23">Gauthier et al., 2010</xref>; <xref ref-type="bibr" rid="bib28">Han et al., 2013</xref>). It remains possible that more detailed analysis will reveal phenotypic differences between gain and loss of human Shank3. In either case, it is currently unclear how opposite changes in Shank3 levels produce psychiatric phenotypes. Different (potentially opposite) biochemical defects arising from decreased and increased Shank dosage could produce psychiatric traits, perhaps by circuit level mechanisms (<xref ref-type="bibr" rid="bib2">Antoine et al., 2019</xref>; <xref ref-type="bibr" rid="bib49">Peixoto et al., 2016</xref>). For example, Shank duplications and hemizygosity could act in different cells or circuits to produce psychiatric traits. Our results provide support for a second possibility. We find that increased and decreased <italic>shn-1</italic> gene dosage produce similar cell autonomous CaV1-BK coupling defects. Two prior studies suggest that bidirectional changes in Shank produce similar defects in Wnt signaling and CaV1 current density (<xref ref-type="bibr" rid="bib30">Harris et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>). Collectively, these results suggest that some biochemical functions of Shank exhibit this unusual pattern of dose sensitivity and consequently could contribute to the pathophysiology of human Shankopathies (i.e. Shank3 mutations, CNVs, or PMS).</p><p>The role of human Shank in CaV1-BK coupling has not been tested. Nonetheless, it seems plausible that this new physiological function could contribute to neuropsychiatric or co-morbid phenotypes associated with human Shankopathies. Consistent with this idea, PMS and human KCNMA1/BK mutations are associated with several shared phenotypes including: autism, developmental delay, intellectual disability, hypotonia, seizures, and gastrointestinal defects (i.e. vomiting, constipation, or diarrhea) (<xref ref-type="bibr" rid="bib4">Bailey et al., 2019</xref>; <xref ref-type="bibr" rid="bib39">Laumonnier et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Phelan and McDermid, 2012</xref>; <xref ref-type="bibr" rid="bib60">Soorya et al., 2013</xref>; <xref ref-type="bibr" rid="bib69">Witmer et al., 2019</xref>). Moreover, BK channels are regulated by two high confidence ASD genes (UBE3A and hnRNP U). BK channels are degraded by the ubiquitin ligase UBE3A (<xref ref-type="bibr" rid="bib65">Sun et al., 2019</xref>), mutations in which cause Angelman’s syndrome. The RNA binding protein hnRNP U promotes translation of <italic>slo-2</italic> mRNA (<xref ref-type="bibr" rid="bib45">Liu et al., 2018</xref>). Collectively, these results support the idea that disrupted CaV1-BK channel coupling could play an important role in shankopathies and that BK channels may represent an important therapeutic target for treating these disorders.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">N2 Bristol</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/">https://cgc.umn.edu/</ext-link></td><td align="left" valign="bottom">N2</td><td align="left" valign="bottom">Wild-type reference</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-1(js379</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Wang et al., 2001</xref></td><td align="left" valign="bottom">NM1968</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nf100</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Santi et al., 2003</xref></td><td align="left" valign="bottom">LY100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-1(js379);slo-2(nf100</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10046</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shk-1(ok1581</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref></td><td align="left" valign="bottom">RB1392</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shk-1(ok1581);slo-2(nf100</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10879</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(tm488</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Oh et al., 2011</xref></td><td align="left" valign="bottom">KP7032</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10151</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu697</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10082</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi26</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref></td><td align="left" valign="bottom">KP7493</td><td align="left" valign="bottom">Pmyo-3::shn-1A MOSSci</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi572</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10696</td><td align="left" valign="bottom">Muscle CRE</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi502</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10497</td><td align="left" valign="bottom">Pan neuron CRE</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu697);nuSi572</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10767</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu697);nuSi502</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10768</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi205</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9234</td><td align="left" valign="bottom">Ubiquitous GFP<sub>1-10</sub></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu604 GFP<sub>11</sub></italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP8587</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu652); nuSi205</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9548</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi470</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10393</td><td align="left" valign="bottom">Muscle CRE</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu652);nuSi470</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10437</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu604);nusi205</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9232</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu542</italic>ΔPDZ)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9898</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>egl-19(nu496</italic>ΔVTTL)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref></td><td align="left" valign="bottom">KP7992</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>egl-19(nu496);shn-1(tm488</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref></td><td align="left" valign="bottom">KP8046</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9814</td><td align="left" valign="bottom">muscle GFP<sub>1-10</sub></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nu725</italic> GFP<sub>11</sub>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10285</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nu725);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10031</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712); slo-2(nu725);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10894</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu542); slo-2(nu725);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10890</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>egl-19(nu496); slo-2(nu725);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10891</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-1(nu678</italic> GFP<sub>11</sub>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9826</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-1(nu678);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10030</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712); slo-1(nu678);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10892</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712);slo-2(nf100</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10880</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu542);slo-2(nf100</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10881</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>egl-19(nu496);slo-2(nf100</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10882</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>nuSi458</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10374</td><td align="left" valign="bottom">muscle Cherry<sub>1-10</sub> SL2 GFP<sub>1-10</sub></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>egl-19(nu722</italic> Cherry<sub>11</sub>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10230</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nu725);egl-19(nu722);nusi458</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10816</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712); slo-2(nu725);egl-19(nu722);nusi458</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10816</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712);vsIs48</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10883</td><td align="left" valign="bottom">vsIs48 is Punc-17::GFP</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nf100);vsIs48</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10884</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712);slo-2(nf100);vsIs48</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10885</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nu725);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10886</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712);slo-2(nu725);nusi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10887</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-1(nu678); slo-2(nf100); nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10895</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nu725); slo-1(js379);nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10896</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>slo-2(nu725);nuSi250</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10897</td><td align="left" valign="bottom">nuSi250 is Punc-129 GFP<sub>1-10</sub></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu712); slo-2(nu725 GFP11);nuSi250</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10898</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>egl-19(nu496); shn-1(nu712</italic>)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10906</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>unc-68(nu664); nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP9802</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>unc-68(nu664); shn-1(tm488); nuSi144</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10040</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><italic>shn-1(nu604,nu652); nuSi502</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP10907</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">OP50</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib9">Brenner, 1974</xref></td><td align="left" valign="bottom">OP50</td><td align="left" valign="bottom">Worm food</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">egl-19 residue 2</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">TTACCTGACATGATGGACAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">shn-1 ∆PDZ 5'</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">gtgattccacgtggtgtcaa</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">shn-1 ∆PDZ 3'</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">gtagctgatatgagtagggg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">shn-1 intron one loxP insertion</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">tcaatttcagAAGTTCCTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">shn-1 3' UTR loxP insertion</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">gaaaaggcatagaatcagtg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">shn-1 intron two insertion for STOP cassette</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">ggggaaagatatgcatctga</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">shn-1 residue 946 insertion</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">CACATCTTCTCGAACGTCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">slo-1 residue 1,121 insertion</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">cccggctcgtactccagtcc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">slo-2 residue 1,092 insertion</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">ctgcgtcttagaccccttct</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Pmyo-3::gfp<sub>1-10</sub></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#3,315</td><td align="left" valign="bottom">muscle GFP<sub>1-10</sub></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Peft-3::gfp<sub>1-10</sub></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#4,524</td><td align="left" valign="bottom">ubiquitous GFP<sub>1-10</sub></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Punc-129::gfp<sub>1-10</sub></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#4,525</td><td align="left" valign="bottom">GFP<sub>1-10</sub> in DA/B neurons</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Ppat-10 Cherry<sub>1-10</sub> SL2 GFP <sub>1-10</sub></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#4,526</td><td align="left" valign="bottom">Cherry<sub>1-10</sub> and GFP<sub>1-10</sub> in muscles</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Pmyo-3::CRE</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#4,527</td><td align="left" valign="bottom">muscle CRE</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom"><italic>Psbt-1::CRE</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#4,528</td><td align="left" valign="bottom">Pan neuron CRE</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom"><italic>Peft-3::CRE</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">KP#4,529</td><td align="left" valign="bottom">germline CRE</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Nemadipine-A</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab145991</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MATLAB R2018a</td><td align="left" valign="bottom">MATLAB</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://fiji.sc/">https://fiji.sc/</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ClampFit</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 9</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Origin 2019</td><td align="left" valign="bottom">OriginLab</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Adobe illustrator 2020</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Strains</title><p>Strain maintenance and genetic manipulation were performed as described (<xref ref-type="bibr" rid="bib9">Brenner, 1974</xref>). Animals were cultivated at room temperature (~22 °C) on agar nematode growth media seeded with OP50 bacteria. Alleles used in this study are described in <xref ref-type="table" rid="table2">Table 2</xref> and are identified in each figure legend. All strains utilized are listed in the Key Resources Table. Transgenic animals were prepared by microinjection, and integrated transgenes were isolated following UV irradiation, as described (<xref ref-type="bibr" rid="bib13">Dittman and Kaplan, 2006</xref>). Single copy transgenes were isolated by the MoSCI and miniMoS techniques (<xref ref-type="bibr" rid="bib20">Frøkjaer-Jensen et al., 2008</xref>; <xref ref-type="bibr" rid="bib21">Frøkjær-Jensen et al., 2014</xref>).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Alleles used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Allele:</th><th align="left" valign="bottom">Description:</th><th align="left" valign="bottom">Reference:</th><th align="left" valign="bottom"/></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>shn-1(tm488</italic>)</td><td align="left" valign="bottom">1537 nt deletion, frameshift at codon 118</td><td align="char" char="." colspan="2" valign="bottom"><xref ref-type="bibr" rid="bib46">Oh et al., 2011</xref></td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu697</italic>)</td><td align="left" valign="bottom">LoxP sites in intron 1 and 3'UTR</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu712</italic>)</td><td align="left" valign="bottom">derived by germline CRE recombination of <italic>nu697</italic></td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu652</italic>)</td><td align="left" valign="bottom">stop cassette (flanked by FLEX sites) in intron two in &quot;OFF&quot; orientation</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu600</italic> GFP<sub>11</sub>)</td><td align="left" valign="bottom">seven copies GFP<sub>11</sub> inserted at codon 945 of SHN-1A</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>shn-1(nu542</italic>ΔPDZ)</td><td align="left" valign="bottom">deletes aa 446–532 of SHN-1A</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>egl-19(nu722</italic> Cherry<sub>11</sub>)</td><td align="left" valign="bottom">six copies sfCherry<sub>11</sub> inserted at codon 2</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>egl-19(nu496</italic>ΔVTTL)</td><td align="left" valign="bottom">WT C-term PAENSSRQHDSRGGSQEDLLLVTTL replaced with PMIHAEDHKKSYF</td><td align="char" char="." colspan="2" valign="bottom"><xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref></td></tr><tr><td align="left" valign="bottom"><italic>unc-68(nu664</italic> GFP<sub>11</sub>)</td><td align="left" valign="bottom">seven copies GFP<sub>11</sub> inserted at codon 3,705 of UNC-68A</td><td align="left" colspan="2" valign="bottom"><xref ref-type="bibr" rid="bib53">Piggott et al., 2021</xref></td></tr><tr><td align="left" valign="bottom"><italic>slo-2(nu725</italic> GFP<sub>11</sub>)</td><td align="left" valign="bottom">seven copies GFP<sub>11</sub> inserted at codon 1,092 of SLO-2A</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>slo-1(nu678</italic> GFP<sub>11</sub>)</td><td align="left" valign="bottom">seven copies GFP<sub>11</sub> inserted at codon 1,130 of SLO-1A</td><td align="left" colspan="2" valign="bottom">This study</td></tr><tr><td align="left" valign="bottom"><italic>slo-1(js379</italic>)</td><td align="left" valign="bottom">Q251stop</td><td align="char" char="." colspan="2" valign="bottom"><xref ref-type="bibr" rid="bib67">Wang et al., 2001</xref></td></tr><tr><td align="left" valign="bottom"><italic>slo-2(nf100</italic>)</td><td align="left" valign="bottom">in frame deletion of aa 450–569</td><td align="char" char="." colspan="2" valign="bottom"><xref ref-type="bibr" rid="bib58">Santi et al., 2003</xref></td></tr><tr><td align="left" valign="bottom"><italic>shk-1(ok1581</italic>)</td><td align="left" valign="bottom">P253stop</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib43">Liu et al., 2011</xref></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></sec><sec id="s4-2"><title><italic>Shn-1</italic> dosage experiments</title><p>Animals with different <italic>shn-1</italic> copy numbers were constructed as follows: 0 copies, <italic>shn-1</italic>(<italic>nu712</italic>) homozygotes; one copy, <italic>unc-17::gfp (LX929</italic>) males were crossed with <italic>shn-1</italic>(<italic>nu712</italic>) homozygotes and <italic>gfp</italic>-expressing hermaphrodites were analyzed; two copies, WT were analyzed; four copies, WT animals homozygous for the single copy transgene expressing SHN-1A in body muscles (<italic>nuSi26</italic>). The <italic>nuSi26</italic> transgene was described in our earlier study (<xref ref-type="bibr" rid="bib55">Pym et al., 2017</xref>).</p></sec><sec id="s4-3"><title>CRISPR alleles</title><p>CRISPR alleles were isolated as described (<xref ref-type="bibr" rid="bib3">Arribere et al., 2014</xref>). Briefly, we used <italic>unc-58</italic> as a co-CRISPR selection to identify edited animals. Animals were injected with two guide RNAs (gRNAs) and two repair templates, one introducing an <italic>unc-58</italic> gain of function mutation and a second modifying a gene of interest. Progeny exhibiting the <italic>unc-58(gf</italic>) uncoordinated phenotype were screened for successful editing of the second locus by PCR. Split GFP and split sfCherry constructs are described in <xref ref-type="bibr" rid="bib18">Feng et al., 2017</xref>. MiniMOS inserts in which Pmyo-3 drives expression of either GFP<sub>1-10</sub> (nuSi144) or sfCherry<sub>1-10</sub> SL2 GFP<sub>1-10</sub> (nuSi458) were created.</p><p>Tissue specific <italic>shn-1</italic> knockout was performed by introducing LoxP sites into intron 1 and the 3’UTR of the endogenous locus, in <italic>shn-1(nu697</italic>), and expressing CRE in muscles (<italic>pat-10</italic> promoter) or neurons (<italic>sbt-1</italic> promoter). Tissue-specific <italic>shn-1</italic> rescue was performed by introducing a stop cassette into intron 2 of <italic>shn-1</italic> using CRISPR, creating the <italic>shn-1(nu652</italic>) allele. The stop cassette consists of a synthetic exon (containing a consensus splice acceptor sequence and stop codons in all reading frames) followed by a 3’ UTR and transcriptional terminator taken from the <italic>flp-28</italic> gene (the 564 bp sequence just 3’ to the <italic>flp-28</italic> stop codon). The stop cassette is flanked by FLEX sites (which are modified loxP sites that mediate CRE induced inversions) (<xref ref-type="bibr" rid="bib59">Schnütgen and Ghyselinck, 2007</xref>). In this manner, orientation of the stop cassette within the <italic>shn-1</italic> locus is controlled by CRE expression. Expression of <italic>shn-1</italic> is reduced when the stop cassette is in the OFF configuration (i.e. the same orientation as <italic>shn-1</italic>) but is unaffected in the ON configuration (opposite orientation). The endogenous <italic>flp-28</italic> gene is located in an intron of W07E11.1 (in the opposite orientation). Consequently, we reasoned that the <italic>flp-28</italic> transcriptional terminator would interfere with <italic>shn-1</italic> expression in an orientation selective manner. A similar strategy was previously described for conditional gene knockouts in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib19">Fisher et al., 2017</xref>).</p></sec><sec id="s4-4"><title>Fluorescence imaging</title><p>Worms were immobilized on 10% agarose pads with 0.3 µl of 0.1 µm diameter polystyrene microspheres (Polysciences 00876–15, 2.5% w/v suspension). Body muscles just anterior to the vulva were imaged. Images were taken with a Nikon A1R confocal, using a 60 X/1.49 NA oil objective, with Nyquist sampling. Image volumes spanning the muscle surface were collected (~10 planes/volume, 0.15 μm between planes, and 0.06 μm /pixel). Maximum intensity projections for each volume were auto-thresholded, and puncta were identified as round fluorescent objects (area &gt;0.1 μm<sup>2</sup>), using analysis of particles. Mean fluorescent intensity in each punctum was analyzed in the raw images. All image analysis was done using FIJI.</p></sec><sec id="s4-5"><title>Electrophysiology</title><p>Whole-cell patch-clamp measurements were performed using a Axopatch 200B amplifier with pClamp 10 software (Molecular Devices). The data were sampled at 10 kHz and filtered at 5 kHz. All recordings were performed at room temperature (~19°C–21°C).</p><p>Muscle AP recordings- The bath solution contained (in mM): NaCl 140, KCl 5, CaCl<sub>2</sub> 5, MgCl<sub>2</sub> 5, dextrose 11 and HEPES 5 (pH 7.2, 320 mOsm). The pipette solution contained (in mM): Kgluconate 120, KOH 20, Tris 5, CaCl<sub>2</sub> 0.25, MgCl<sub>2</sub> 4, sucrose 36, EGTA 5 (or BAPTA 5), and Na<sub>2</sub>ATP 4 (pH 7.2, 323 mOsm). Spontaneous APs were recorded in current-clamp without current injection. Cell resistance (R<sub>in</sub>) was measured following a 10 pA pulse injection. AP traces were analyzed in Matlab. APs were defined as depolarizations lasting &lt;150ms. PPs were defined as depolarizations lasting &gt;150ms.</p><p>K<sup>+</sup> current recordings <italic>-</italic> The bath solution contained (in mM): NaCl 140, KCl 5, CaCl<sub>2</sub> 5, MgCl<sub>2</sub> 5, dextrose 11 and HEPES 5 (pH 7.2, 320 mOsm). For Ik<sub>loCl</sub> recordings, the pipette solution contained (in mM): Kgluconate 120, KOH 20, Tris 5, CaCl<sub>2</sub> 0.25, MgCl<sub>2</sub> 4, sucrose 36, EGTA 5, and Na<sub>2</sub>ATP 4 (pH 7.2, 323 mOsm). For Ik<sub>hiCl</sub> recordings, the pipette solution contained (in mM): KCl 120, KOH 20, Tris 5, CaCl<sub>2</sub> 0.25, MgCl<sub>2</sub> 4, sucrose 36, EGTA 5 (or BAPTA 5), and Na<sub>2</sub>ATP 4 (pH 7.2, 323 mOsm). The voltage-clamp protocol consisted of –60 mV for 50ms, –90 mV for 50ms, test voltage (from –60 mV to +60 mV) 150ms. The repetitive stimulus protocol was –20 mV for 50ms, + 30 mV for 50ms, which was repeated 20 times. In figures, we show outward currents evoked at +30 mV, which corresponds to the peak amplitude of muscle APs. In some recordings, EGL-19 channels were blocked by adding 5 μM nemadipine to the pipette solution. Patch clamp recording of Ik<sub>hiCl</sub> in ACh motor neurons was done using solutions described above for the muscle recordings. ACh neurons were identified for patching by expression of an <italic>unc-17</italic> transcriptional reporter (P<italic>unc-17</italic>::GFP).</p></sec><sec id="s4-6"><title>Statistical methods</title><p>For normally distributed data, significant differences were assessed with unpaired t tests (for two groups) or one way ANOVA with post-hoc Dunn’s multiple comparisons test (for &gt;2 groups). For non-normal data, differences were assessed by Mann-Whitney (two groups) or Kruskal-Wallis test with post-hoc Dunn’s multiple comparisons test ( &gt; 2 groups). Data graphing and statistics were performed in GraphPad Prism 9. No statistical method was used to select sample sizes. Data shown in each figure represent contemporaneous measurements from mutant and control animals over a period of 1–2 weeks. For electrophysiology, data points represent mean values for individual neuron or muscle recordings (which were considered biological replicates). For imaging studies, data points represent mean puncta fluorescence values in individual animals (which were considered biological replicates). All data obtained in each experiment were analyzed, without any exclusions.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Funding acquisition, Investigation, Writing - original draft, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-75140-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed in this study are included in the manuscript.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the following for strains, advice, reagents, and comments on the manuscript: <italic>C. elegans</italic> genetics stock center (CGC), S Mitani, and members of the Kaplan lab. This work was supported by an NIH research grant to JK (NS32196). The CGC is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PR</given-names></name><name><surname>Constanti</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>DA</given-names></name><name><surname>Clark</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Intracellular Ca2+ activates a fast voltage-sensitive K+ current in vertebrate sympathetic neurones</article-title><source>Nature</source><volume>296</volume><fpage>746</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1038/296746a0</pub-id><pub-id pub-id-type="pmid">6280066</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoine</surname><given-names>MW</given-names></name><name><surname>Langberg</surname><given-names>T</given-names></name><name><surname>Schnepel</surname><given-names>P</given-names></name><name><surname>Feldman</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models</article-title><source>Neuron</source><volume>101</volume><fpage>648</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.026</pub-id><pub-id pub-id-type="pmid">30679017</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arribere</surname><given-names>JA</given-names></name><name><surname>Bell</surname><given-names>RT</given-names></name><name><surname>Fu</surname><given-names>BXH</given-names></name><name><surname>Artiles</surname><given-names>KL</given-names></name><name><surname>Hartman</surname><given-names>PS</given-names></name><name><surname>Fire</surname><given-names>AZ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>198</volume><fpage>837</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1534/genetics.114.169730</pub-id><pub-id pub-id-type="pmid">25161212</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>CS</given-names></name><name><surname>Moldenhauer</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name><name><surname>Keros</surname><given-names>S</given-names></name><name><surname>Meredith</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>KCNMA1-linked channelopathy</article-title><source>Journal of General Physiology</source><volume>151</volume><fpage>1173</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1085/jgp.201912457</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JN</given-names></name><name><surname>Magleby</surname><given-names>KL</given-names></name><name><surname>Pallotta</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Properties of single calcium-activated potassium channels in cultured rat muscle</article-title><source>The Journal of Physiology</source><volume>331</volume><fpage>211</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1982.sp014370</pub-id><pub-id pub-id-type="pmid">6296366</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkefeld</surname><given-names>H</given-names></name><name><surname>Sailer</surname><given-names>CA</given-names></name><name><surname>Bildl</surname><given-names>W</given-names></name><name><surname>Rohde</surname><given-names>V</given-names></name><name><surname>Thumfart</surname><given-names>J-O</given-names></name><name><surname>Eble</surname><given-names>S</given-names></name><name><surname>Klugbauer</surname><given-names>N</given-names></name><name><surname>Reisinger</surname><given-names>E</given-names></name><name><surname>Bischofberger</surname><given-names>J</given-names></name><name><surname>Oliver</surname><given-names>D</given-names></name><name><surname>Knaus</surname><given-names>H-G</given-names></name><name><surname>Schulte</surname><given-names>U</given-names></name><name><surname>Fakler</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling</article-title><source>Science (New York, N.Y.)</source><volume>314</volume><fpage>615</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1126/science.1132915</pub-id><pub-id pub-id-type="pmid">17068255</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaglia</surname><given-names>M.C.</given-names></name><name><surname>Giorda</surname><given-names>R</given-names></name><name><surname>Mani</surname><given-names>E</given-names></name><name><surname>Aceti</surname><given-names>G</given-names></name><name><surname>Anderlid</surname><given-names>BM</given-names></name><name><surname>Baroncini</surname><given-names>A</given-names></name><name><surname>Pramparo</surname><given-names>T</given-names></name><name><surname>Zuffardi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome</article-title><source>Journal of Medical Genetics</source><volume>43</volume><fpage>822</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1136/jmg.2005.038604</pub-id><pub-id pub-id-type="pmid">16284256</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaglia</surname><given-names>MC</given-names></name><name><surname>Giorda</surname><given-names>R</given-names></name><name><surname>Beri</surname><given-names>S</given-names></name><name><surname>De Agostini</surname><given-names>C</given-names></name><name><surname>Novara</surname><given-names>F</given-names></name><name><surname>Fichera</surname><given-names>M</given-names></name><name><surname>Grillo</surname><given-names>L</given-names></name><name><surname>Galesi</surname><given-names>O</given-names></name><name><surname>Vetro</surname><given-names>A</given-names></name><name><surname>Ciccone</surname><given-names>R</given-names></name><name><surname>Bonati</surname><given-names>MT</given-names></name><name><surname>Giglio</surname><given-names>S</given-names></name><name><surname>Guerrini</surname><given-names>R</given-names></name><name><surname>Osimani</surname><given-names>S</given-names></name><name><surname>Marelli</surname><given-names>S</given-names></name><name><surname>Zucca</surname><given-names>C</given-names></name><name><surname>Grasso</surname><given-names>R</given-names></name><name><surname>Borgatti</surname><given-names>R</given-names></name><name><surname>Mani</surname><given-names>E</given-names></name><name><surname>Motta</surname><given-names>C</given-names></name><name><surname>Molteni</surname><given-names>M</given-names></name><name><surname>Romano</surname><given-names>C</given-names></name><name><surname>Greco</surname><given-names>D</given-names></name><name><surname>Reitano</surname><given-names>S</given-names></name><name><surname>Baroncini</surname><given-names>A</given-names></name><name><surname>Lapi</surname><given-names>E</given-names></name><name><surname>Cecconi</surname><given-names>A</given-names></name><name><surname>Arrigo</surname><given-names>G</given-names></name><name><surname>Patricelli</surname><given-names>MG</given-names></name><name><surname>Pantaleoni</surname><given-names>C</given-names></name><name><surname>D’Arrigo</surname><given-names>S</given-names></name><name><surname>Riva</surname><given-names>D</given-names></name><name><surname>Sciacca</surname><given-names>F</given-names></name><name><surname>Dalla Bernardina</surname><given-names>B</given-names></name><name><surname>Zoccante</surname><given-names>L</given-names></name><name><surname>Darra</surname><given-names>F</given-names></name><name><surname>Termine</surname><given-names>C</given-names></name><name><surname>Maserati</surname><given-names>E</given-names></name><name><surname>Bigoni</surname><given-names>S</given-names></name><name><surname>Priolo</surname><given-names>E</given-names></name><name><surname>Bottani</surname><given-names>A</given-names></name><name><surname>Gimelli</surname><given-names>S</given-names></name><name><surname>Bena</surname><given-names>F</given-names></name><name><surname>Brusco</surname><given-names>A</given-names></name><name><surname>di Gregorio</surname><given-names>E</given-names></name><name><surname>Bagnasco</surname><given-names>I</given-names></name><name><surname>Giussani</surname><given-names>U</given-names></name><name><surname>Nitsch</surname><given-names>L</given-names></name><name><surname>Politi</surname><given-names>P</given-names></name><name><surname>Martinez-Frias</surname><given-names>ML</given-names></name><name><surname>Martínez-Fernández</surname><given-names>ML</given-names></name><name><surname>Martínez Guardia</surname><given-names>N</given-names></name><name><surname>Bremer</surname><given-names>A</given-names></name><name><surname>Anderlid</surname><given-names>BM</given-names></name><name><surname>Zuffardi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002173</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002173</pub-id><pub-id pub-id-type="pmid">21779178</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>The genetics of <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>77</volume><fpage>71</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1093/genetics/77.1.71</pub-id><pub-id pub-id-type="pmid">4366476</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Packer</surname><given-names>JS</given-names></name><name><surname>Ramani</surname><given-names>V</given-names></name><name><surname>Cusanovich</surname><given-names>DA</given-names></name><name><surname>Huynh</surname><given-names>C</given-names></name><name><surname>Daza</surname><given-names>R</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Furlan</surname><given-names>SN</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Adey</surname><given-names>A</given-names></name><name><surname>Waterston</surname><given-names>RH</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comprehensive single-cell transcriptional profiling of a multicellular organism</article-title><source>Science (New York, N.Y.)</source><volume>357</volume><fpage>661</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1126/science.aam8940</pub-id><pub-id pub-id-type="pmid">28818938</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Kronengold</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Gazula</surname><given-names>V-R</given-names></name><name><surname>Brown</surname><given-names>MR</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Sigworth</surname><given-names>FJ</given-names></name><name><surname>Salkoff</surname><given-names>L</given-names></name><name><surname>Kaczmarek</surname><given-names>LK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The N-terminal domain of Slack determines the formation and trafficking of Slick/Slack heteromeric sodium-activated potassium channels</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>5654</fpage><lpage>5665</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5978-08.2009</pub-id><pub-id pub-id-type="pmid">19403831</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>GF</given-names></name><name><surname>Castillo</surname><given-names>K</given-names></name><name><surname>Enrique</surname><given-names>N</given-names></name><name><surname>Carrasquel-Ursulaez</surname><given-names>W</given-names></name><name><surname>Castillo</surname><given-names>JP</given-names></name><name><surname>Milesi</surname><given-names>V</given-names></name><name><surname>Neely</surname><given-names>A</given-names></name><name><surname>Alvarez</surname><given-names>O</given-names></name><name><surname>Ferreira</surname><given-names>G</given-names></name><name><surname>González</surname><given-names>C</given-names></name><name><surname>Latorre</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A BK (Slo1) channel journey from molecule to physiology</article-title><source>Channels (Austin, Tex.)</source><volume>7</volume><fpage>442</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.4161/chan.26242</pub-id><pub-id pub-id-type="pmid">24025517</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dittman</surname><given-names>JS</given-names></name><name><surname>Kaplan</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Factors regulating the abundance and localization of synaptobrevin in the plasma membrane</article-title><source>PNAS</source><volume>103</volume><fpage>11399</fpage><lpage>11404</lpage><pub-id pub-id-type="doi">10.1073/pnas.0600784103</pub-id><pub-id pub-id-type="pmid">16844789</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dopico</surname><given-names>AM</given-names></name><name><surname>Bukiya</surname><given-names>AN</given-names></name><name><surname>Jaggar</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Calcium- and voltage-gated BK channels in vascular smooth muscle</article-title><source>Pflugers Archiv</source><volume>470</volume><fpage>1271</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1007/s00424-018-2151-y</pub-id><pub-id pub-id-type="pmid">29748711</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>CM</given-names></name><name><surname>Betancur</surname><given-names>C</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name><name><surname>Bockmann</surname><given-names>J</given-names></name><name><surname>Chaste</surname><given-names>P</given-names></name><name><surname>Fauchereau</surname><given-names>F</given-names></name><name><surname>Nygren</surname><given-names>G</given-names></name><name><surname>Rastam</surname><given-names>M</given-names></name><name><surname>Gillberg</surname><given-names>IC</given-names></name><name><surname>Anckarsäter</surname><given-names>H</given-names></name><name><surname>Sponheim</surname><given-names>E</given-names></name><name><surname>Goubran-Botros</surname><given-names>H</given-names></name><name><surname>Delorme</surname><given-names>R</given-names></name><name><surname>Chabane</surname><given-names>N</given-names></name><name><surname>Mouren-Simeoni</surname><given-names>M-C</given-names></name><name><surname>de Mas</surname><given-names>P</given-names></name><name><surname>Bieth</surname><given-names>E</given-names></name><name><surname>Rogé</surname><given-names>B</given-names></name><name><surname>Héron</surname><given-names>D</given-names></name><name><surname>Burglen</surname><given-names>L</given-names></name><name><surname>Gillberg</surname><given-names>C</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name><name><surname>Bourgeron</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title><source>Nature Genetics</source><volume>39</volume><fpage>25</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1038/ng1933</pub-id><pub-id pub-id-type="pmid">17173049</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgerton</surname><given-names>JR</given-names></name><name><surname>Reinhart</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Distinct contributions of small and large conductance Ca2+-activated K+ channels to rat Purkinje neuron function</article-title><source>The Journal of Physiology</source><volume>548</volume><fpage>53</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2002.027854</pub-id><pub-id pub-id-type="pmid">12576503</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Failla</surname><given-names>P</given-names></name><name><surname>Romano</surname><given-names>C</given-names></name><name><surname>Alberti</surname><given-names>A</given-names></name><name><surname>Vasta</surname><given-names>A</given-names></name><name><surname>Buono</surname><given-names>S</given-names></name><name><surname>Castiglia</surname><given-names>L</given-names></name><name><surname>Luciano</surname><given-names>D</given-names></name><name><surname>Di Benedetto</surname><given-names>D</given-names></name><name><surname>Fichera</surname><given-names>M</given-names></name><name><surname>Galesi</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Schizophrenia in a patient with subtelomeric duplication of chromosome 22q</article-title><source>Clinical Genetics</source><volume>71</volume><fpage>599</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0004.2007.00819.x</pub-id><pub-id pub-id-type="pmid">17539913</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Sekine</surname><given-names>S</given-names></name><name><surname>Pessino</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Leonetti</surname><given-names>MD</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Improved split fluorescent proteins for endogenous protein labeling</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>370</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00494-8</pub-id><pub-id pub-id-type="pmid">28851864</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>YE</given-names></name><name><surname>Yang</surname><given-names>HH</given-names></name><name><surname>Isaacman-Beck</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Gohl</surname><given-names>DM</given-names></name><name><surname>Clandinin</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>FlpStop, a tool for conditional gene control in <italic>Drosophila</italic></article-title><source>eLife</source><volume>6</volume><elocation-id>e22279</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.22279</pub-id><pub-id pub-id-type="pmid">28211790</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frøkjaer-Jensen</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>MW</given-names></name><name><surname>Hopkins</surname><given-names>CE</given-names></name><name><surname>Newman</surname><given-names>BJ</given-names></name><name><surname>Thummel</surname><given-names>JM</given-names></name><name><surname>Olesen</surname><given-names>S-P</given-names></name><name><surname>Grunnet</surname><given-names>M</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Single-copy insertion of transgenes in <italic>Caenorhabditis elegans</italic></article-title><source>Nature Genetics</source><volume>40</volume><fpage>1375</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.1038/ng.248</pub-id><pub-id pub-id-type="pmid">18953339</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frøkjær-Jensen</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>MW</given-names></name><name><surname>Sarov</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Flibotte</surname><given-names>S</given-names></name><name><surname>LaBella</surname><given-names>M</given-names></name><name><surname>Pozniakovsky</surname><given-names>A</given-names></name><name><surname>Moerman</surname><given-names>DG</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Random and targeted transgene insertion in <italic>Caenorhabditis elegans</italic> using a modified Mos1 transposon</article-title><source>Nature Methods</source><volume>11</volume><fpage>529</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2889</pub-id><pub-id pub-id-type="pmid">24820376</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Zhen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Action potentials drive body wall muscle contractions in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>108</volume><fpage>2557</fpage><lpage>2562</lpage><pub-id pub-id-type="doi">10.1073/pnas.1012346108</pub-id><pub-id pub-id-type="pmid">21248227</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>J</given-names></name><name><surname>Champagne</surname><given-names>N</given-names></name><name><surname>Lafrenière</surname><given-names>RG</given-names></name><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Brustein</surname><given-names>E</given-names></name><name><surname>Lapointe</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Côté</surname><given-names>M</given-names></name><name><surname>Noreau</surname><given-names>A</given-names></name><name><surname>Hamdan</surname><given-names>FF</given-names></name><name><surname>Addington</surname><given-names>AM</given-names></name><name><surname>Rapoport</surname><given-names>JL</given-names></name><name><surname>Delisi</surname><given-names>LE</given-names></name><name><surname>Krebs</surname><given-names>MO</given-names></name><name><surname>Joober</surname><given-names>R</given-names></name><name><surname>Fathalli</surname><given-names>F</given-names></name><name><surname>Mouaffak</surname><given-names>F</given-names></name><name><surname>Haghighi</surname><given-names>AP</given-names></name><name><surname>Néri</surname><given-names>C</given-names></name><name><surname>Dubé</surname><given-names>MP</given-names></name><name><surname>Samuels</surname><given-names>ME</given-names></name><name><surname>Marineau</surname><given-names>C</given-names></name><name><surname>Stone</surname><given-names>EA</given-names></name><name><surname>Awadalla</surname><given-names>P</given-names></name><name><surname>Barker</surname><given-names>PA</given-names></name><name><surname>Carbonetto</surname><given-names>S</given-names></name><name><surname>Drapeau</surname><given-names>P</given-names></name><name><surname>Rouleau</surname><given-names>GA</given-names></name><collab>S2D Team</collab></person-group><year iso-8601-date="2010">2010</year><article-title>De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia</article-title><source>PNAS</source><volume>107</volume><fpage>7863</fpage><lpage>7868</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906232107</pub-id><pub-id pub-id-type="pmid">20385823</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>JR</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dynamic control of presynaptic Ca(2+) inflow by fast-inactivating K(+) channels in hippocampal mossy fiber boutons</article-title><source>Neuron</source><volume>28</volume><fpage>927</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)00164-1</pub-id><pub-id pub-id-type="pmid">11163277</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golding</surname><given-names>NL</given-names></name><name><surname>Jung</surname><given-names>HY</given-names></name><name><surname>Mickus</surname><given-names>T</given-names></name><name><surname>Spruston</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Dendritic calcium spike initiation and repolarization are controlled by distinct potassium channel subtypes in CA1 pyramidal neurons</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>8789</fpage><lpage>8798</lpage><pub-id pub-id-type="pmid">10516298</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabrucker</surname><given-names>AM</given-names></name><name><surname>Schmeisser</surname><given-names>MJ</given-names></name><name><surname>Schoen</surname><given-names>M</given-names></name><name><surname>Boeckers</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies</article-title><source>Trends in Cell Biology</source><volume>21</volume><fpage>594</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2011.07.003</pub-id><pub-id pub-id-type="pmid">21840719</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griguoli</surname><given-names>M</given-names></name><name><surname>Sgritta</surname><given-names>M</given-names></name><name><surname>Cherubini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Presynaptic BK channels control transmitter release: physiological relevance and potential therapeutic implications</article-title><source>The Journal of Physiology</source><volume>594</volume><fpage>3489</fpage><lpage>3500</lpage><pub-id pub-id-type="doi">10.1113/JP271841</pub-id><pub-id pub-id-type="pmid">26969302</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Holder</surname><given-names>JL</given-names><suffix>Jr</suffix></name><name><surname>Schaaf</surname><given-names>CP</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>SW</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Breman</surname><given-names>AM</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>H-C</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties</article-title><source>Nature</source><volume>503</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1038/nature12630</pub-id><pub-id pub-id-type="pmid">24153177</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Z-J</given-names></name><name><surname>Bey</surname><given-names>AL</given-names></name><name><surname>Lay</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Berta</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Y-H</given-names></name><name><surname>Ji</surname><given-names>R-R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons</article-title><source>Neuron</source><volume>92</volume><fpage>1279</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.007</pub-id><pub-id pub-id-type="pmid">27916453</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>KP</given-names></name><name><surname>Akbergenova</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>RW</given-names></name><name><surname>Baas-Thomas</surname><given-names>MS</given-names></name><name><surname>Littleton</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Shank Modulates Postsynaptic Wnt Signaling to Regulate Synaptic Development</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>5820</fpage><lpage>5832</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4279-15.2016</pub-id><pub-id pub-id-type="pmid">27225771</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingiosi</surname><given-names>AM</given-names></name><name><surname>Schoch</surname><given-names>H</given-names></name><name><surname>Wintler</surname><given-names>T</given-names></name><name><surname>Singletary</surname><given-names>KG</given-names></name><name><surname>Righelli</surname><given-names>D</given-names></name><name><surname>Roser</surname><given-names>LG</given-names></name><name><surname>Medina</surname><given-names>E</given-names></name><name><surname>Risso</surname><given-names>D</given-names></name><name><surname>Frank</surname><given-names>MG</given-names></name><name><surname>Peixoto</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Shank3 modulates sleep and expression of circadian transcription factors</article-title><source>eLife</source><volume>8</volume><elocation-id>e42819</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42819</pub-id><pub-id pub-id-type="pmid">30973326</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>MB</given-names></name><name><surname>Konnerth</surname><given-names>A</given-names></name><name><surname>Augustine</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Action potential broadening and frequency-dependent facilitation of calcium signals in pituitary nerve terminals</article-title><source>PNAS</source><volume>88</volume><fpage>380</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.2.380</pub-id><pub-id pub-id-type="pmid">1988937</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>YH</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modeling autism by SHANK gene mutations in mice</article-title><source>Neuron</source><volume>78</volume><fpage>8</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.016</pub-id><pub-id pub-id-type="pmid">23583105</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jospin</surname><given-names>M</given-names></name><name><surname>Jacquemond</surname><given-names>V</given-names></name><name><surname>Mariol</surname><given-names>M-C</given-names></name><name><surname>Ségalat</surname><given-names>L</given-names></name><name><surname>Allard</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The L-type voltage-dependent Ca2+ channel EGL-19 controls body wall muscle function in <italic>Caenorhabditis elegans</italic></article-title><source>The Journal of Cell Biology</source><volume>159</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1083/jcb.200203055</pub-id><pub-id pub-id-type="pmid">12391025</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Pierce-Shimomura</surname><given-names>JT</given-names></name><name><surname>Oh</surname><given-names>HJ</given-names></name><name><surname>Johnson</surname><given-names>BE</given-names></name><name><surname>Goodman</surname><given-names>MB</given-names></name><name><surname>McIntire</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The dystrophin complex controls bk channel localization and muscle activity in <italic>Caenorhabditis elegans</italic></article-title><source>PLOS Genetics</source><volume>5</volume><elocation-id>e1000780</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000780</pub-id><pub-id pub-id-type="pmid">20019812</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kole</surname><given-names>MHP</given-names></name><name><surname>Letzkus</surname><given-names>JJ</given-names></name><name><surname>Stuart</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Axon initial segment Kv1 channels control axonal action potential waveform and synaptic efficacy</article-title><source>Neuron</source><volume>55</volume><fpage>633</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.031</pub-id><pub-id pub-id-type="pmid">17698015</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>TCY</given-names></name><name><surname>Hui</surname><given-names>K</given-names></name><name><surname>Kostelecki</surname><given-names>W</given-names></name><name><surname>Ricker</surname><given-names>N</given-names></name><name><surname>Selman</surname><given-names>G</given-names></name><name><surname>Feng</surname><given-names>ZP</given-names></name><name><surname>Roy</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels</article-title><source>PLOS Genetics</source><volume>4</volume><elocation-id>e1000067</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000067</pub-id><pub-id pub-id-type="pmid">18464914</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latorre</surname><given-names>R</given-names></name><name><surname>Castillo</surname><given-names>K</given-names></name><name><surname>Carrasquel-Ursulaez</surname><given-names>W</given-names></name><name><surname>Sepulveda</surname><given-names>RV</given-names></name><name><surname>Gonzalez-Nilo</surname><given-names>F</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Alvarez</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular Determinants of BK Channel Functional Diversity and Functioning</article-title><source>Physiological Reviews</source><volume>97</volume><fpage>39</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1152/physrev.00001.2016</pub-id><pub-id pub-id-type="pmid">27807200</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laumonnier</surname><given-names>F</given-names></name><name><surname>Roger</surname><given-names>S</given-names></name><name><surname>Guérin</surname><given-names>P</given-names></name><name><surname>Molinari</surname><given-names>F</given-names></name><name><surname>M’rad</surname><given-names>R</given-names></name><name><surname>Cahard</surname><given-names>D</given-names></name><name><surname>Belhadj</surname><given-names>A</given-names></name><name><surname>Halayem</surname><given-names>M</given-names></name><name><surname>Persico</surname><given-names>AM</given-names></name><name><surname>Elia</surname><given-names>M</given-names></name><name><surname>Romano</surname><given-names>V</given-names></name><name><surname>Holbert</surname><given-names>S</given-names></name><name><surname>Andres</surname><given-names>C</given-names></name><name><surname>Chaabouni</surname><given-names>H</given-names></name><name><surname>Colleaux</surname><given-names>L</given-names></name><name><surname>Constant</surname><given-names>J</given-names></name><name><surname>Le Guennec</surname><given-names>J-Y</given-names></name><name><surname>Briault</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation</article-title><source>The American Journal of Psychiatry</source><volume>163</volume><fpage>1622</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1176/ajp.2006.163.9.1622</pub-id><pub-id pub-id-type="pmid">16946189</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Eom</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The structural flexibility of the shank1 PDZ domain is important for its binding to different ligands</article-title><source>Biochemical and Biophysical Research Communications</source><volume>407</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.02.141</pub-id><pub-id pub-id-type="pmid">21376703</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lilja</surname><given-names>J</given-names></name><name><surname>Zacharchenko</surname><given-names>T</given-names></name><name><surname>Georgiadou</surname><given-names>M</given-names></name><name><surname>Jacquemet</surname><given-names>G</given-names></name><name><surname>De Franceschi</surname><given-names>N</given-names></name><name><surname>Peuhu</surname><given-names>E</given-names></name><name><surname>Hamidi</surname><given-names>H</given-names></name><name><surname>Pouwels</surname><given-names>J</given-names></name><name><surname>Martens</surname><given-names>V</given-names></name><name><surname>Nia</surname><given-names>FH</given-names></name><name><surname>Beifuss</surname><given-names>M</given-names></name><name><surname>Boeckers</surname><given-names>T</given-names></name><name><surname>Kreienkamp</surname><given-names>H-J</given-names></name><name><surname>Barsukov</surname><given-names>IL</given-names></name><name><surname>Ivaska</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>292</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/ncb3487</pub-id><pub-id pub-id-type="pmid">28263956</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>ZW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Presynaptic Ca2+/calmodulin-dependent protein kinase II modulates neurotransmitter release by activating BK channels at <italic>Caenorhabditis elegans</italic> neuromuscular junction</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>10404</fpage><lpage>10413</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5634-06.2007</pub-id><pub-id pub-id-type="pmid">17898212</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Salkoff</surname><given-names>L</given-names></name><name><surname>Kotlikoff</surname><given-names>MI</given-names></name><name><surname>Wang</surname><given-names>ZW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Genetic dissection of ion currents underlying all-or-none action potentials in <italic>C. elegans</italic> body-wall muscle cells</article-title><source>The Journal of Physiology</source><volume>589</volume><fpage>101</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2010.200683</pub-id><pub-id pub-id-type="pmid">21059759</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>ZW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SLO-2 potassium channel is an important regulator of neurotransmitter release in <italic>Caenorhabditis elegans</italic></article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5155</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6155</pub-id><pub-id pub-id-type="pmid">25300429</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Wang</surname><given-names>ZW</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>HRPU-2, a Homolog of Mammalian hnRNP U, Regulates Synaptic Transmission by Controlling the Expression of SLO-2 Potassium Channel in <italic>Caenorhabditis elegans</italic></article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>1073</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1991-17.2017</pub-id><pub-id pub-id-type="pmid">29217678</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>WC</given-names></name><name><surname>Song</surname><given-names>HO</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ANK repeat-domain of SHN-1 Is indispensable for in vivo SHN-1 function in <italic>C. elegans</italic></article-title><source>Molecules and Cells</source><volume>31</volume><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1007/s10059-011-0007-9</pub-id><pub-id pub-id-type="pmid">21191812</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Packer</surname><given-names>JS</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Huynh</surname><given-names>C</given-names></name><name><surname>Sivaramakrishnan</surname><given-names>P</given-names></name><name><surname>Preston</surname><given-names>E</given-names></name><name><surname>Dueck</surname><given-names>H</given-names></name><name><surname>Stefanik</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>K</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Waterston</surname><given-names>RH</given-names></name><name><surname>Murray</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A lineage-resolved molecular atlas of <italic>C. elegans</italic> embryogenesis at single-cell resolution</article-title><source>Science (New York, N.Y.)</source><volume>365</volume><elocation-id>eaax1971</elocation-id><pub-id pub-id-type="doi">10.1126/science.aax1971</pub-id><pub-id pub-id-type="pmid">31488706</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peça</surname><given-names>J</given-names></name><name><surname>Feliciano</surname><given-names>C</given-names></name><name><surname>Ting</surname><given-names>JT</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wells</surname><given-names>MF</given-names></name><name><surname>Venkatraman</surname><given-names>TN</given-names></name><name><surname>Lascola</surname><given-names>CD</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title><source>Nature</source><volume>472</volume><fpage>437</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/nature09965</pub-id><pub-id pub-id-type="pmid">21423165</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peixoto</surname><given-names>RT</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Croney</surname><given-names>DM</given-names></name><name><surname>Kozorovitskiy</surname><given-names>Y</given-names></name><name><surname>Sabatini</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Early hyperactivity and precocious maturation of corticostriatal circuits in Shank3B(-/-) mice</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>716</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1038/nn.4260</pub-id><pub-id pub-id-type="pmid">26928064</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perfitt</surname><given-names>TL</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Dickerson</surname><given-names>MT</given-names></name><name><surname>Stephenson</surname><given-names>JR</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Jacobson</surname><given-names>DA</given-names></name><name><surname>Colbran</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIalpha-Shank3 Interaction</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>2000</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0893-19.2020</pub-id><pub-id pub-id-type="pmid">32019829</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>OH</given-names></name><name><surname>Maruyama</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Calcium-activated potassium channels and their role in secretion</article-title><source>Nature</source><volume>307</volume><fpage>693</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1038/307693a0</pub-id><pub-id pub-id-type="pmid">6321995</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>K</given-names></name><name><surname>McDermid</surname><given-names>HE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)</article-title><source>Molecular Syndromology</source><volume>2</volume><fpage>186</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1159/000334260</pub-id><pub-id pub-id-type="pmid">22670140</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piggott</surname><given-names>CA</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Nurrish</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>JM</given-names></name><name><surname>Chisholm</surname><given-names>AD</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>Caenorhabditis elegans</italic> Junctophilin has tissue-specific functions and regulates neurotransmission with extended-synaptotagmin</article-title><source>Genetics</source><volume>218</volume><elocation-id>iyab063</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyab063</pub-id><pub-id pub-id-type="pmid">33871019</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psychiatric Genomics</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis</article-title><source>Lancet (London, England)</source><volume>381</volume><fpage>1371</fpage><lpage>1379</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)62129-1</pub-id><pub-id pub-id-type="pmid">23453885</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pym</surname><given-names>E</given-names></name><name><surname>Sasidharan</surname><given-names>N</given-names></name><name><surname>Thompson-Peer</surname><given-names>KL</given-names></name><name><surname>Simon</surname><given-names>DJ</given-names></name><name><surname>Anselmo</surname><given-names>A</given-names></name><name><surname>Sadreyev</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>Q</given-names></name><name><surname>Nurrish</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Shank is a dose-dependent regulator of Cav1 calcium current and CREB target expression</article-title><source>eLife</source><volume>6</volume><elocation-id>e18931</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18931</pub-id><pub-id pub-id-type="pmid">28477407</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>Y</given-names></name><name><surname>Shaw</surname><given-names>CA</given-names></name><name><surname>Dawson</surname><given-names>BC</given-names></name><name><surname>Dugas</surname><given-names>DV</given-names></name><name><surname>Al-Mohtaseb</surname><given-names>Z</given-names></name><name><surname>Hill</surname><given-names>DE</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protein interactome reveals converging molecular pathways among autism disorders</article-title><source>Science Translational Medicine</source><volume>3</volume><elocation-id>86ra49</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3002166</pub-id><pub-id pub-id-type="pmid">21653829</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancar</surname><given-names>F</given-names></name><name><surname>Touroutine</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Oh</surname><given-names>HJ</given-names></name><name><surname>Gendrel</surname><given-names>M</given-names></name><name><surname>Bessereau</surname><given-names>JL</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Zhen</surname><given-names>M</given-names></name><name><surname>Richmond</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The dystrophin-associated protein complex maintains muscle excitability by regulating Ca(2+)-dependent K(+)</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>33501</fpage><lpage>33510</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.227678</pub-id><pub-id pub-id-type="pmid">21795674</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santi</surname><given-names>CM</given-names></name><name><surname>Yuan</surname><given-names>A</given-names></name><name><surname>Fawcett</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>ZW</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Nonet</surname><given-names>ML</given-names></name><name><surname>Wei</surname><given-names>A</given-names></name><name><surname>Rojas</surname><given-names>P</given-names></name><name><surname>Salkoff</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dissection of K+ currents in <italic>Caenorhabditis elegans</italic> muscle cells by genetics and RNA interference</article-title><source>PNAS</source><volume>100</volume><fpage>14391</fpage><lpage>14396</lpage><pub-id pub-id-type="doi">10.1073/pnas.1935976100</pub-id><pub-id pub-id-type="pmid">14612577</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnütgen</surname><given-names>F</given-names></name><name><surname>Ghyselinck</surname><given-names>NB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Adopting the good reFLEXes when generating conditional alterations in the mouse genome</article-title><source>Transgenic Research</source><volume>16</volume><fpage>405</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1007/s11248-007-9089-8</pub-id><pub-id pub-id-type="pmid">17415672</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soorya</surname><given-names>L</given-names></name><name><surname>Kolevzon</surname><given-names>A</given-names></name><name><surname>Zweifach</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>T</given-names></name><name><surname>Dobry</surname><given-names>Y</given-names></name><name><surname>Schwartz</surname><given-names>L</given-names></name><name><surname>Frank</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>AT</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Parkhomenko</surname><given-names>E</given-names></name><name><surname>Halpern</surname><given-names>D</given-names></name><name><surname>Grodberg</surname><given-names>D</given-names></name><name><surname>Angarita</surname><given-names>B</given-names></name><name><surname>Willner</surname><given-names>JP</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Canitano</surname><given-names>R</given-names></name><name><surname>Chaplin</surname><given-names>W</given-names></name><name><surname>Betancur</surname><given-names>C</given-names></name><name><surname>Buxbaum</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency</article-title><source>Molecular Autism</source><volume>4</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/2040-2392-4-18</pub-id><pub-id pub-id-type="pmid">23758760</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speed</surname><given-names>HE</given-names></name><name><surname>Kouser</surname><given-names>M</given-names></name><name><surname>Xuan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Duong</surname><given-names>A</given-names></name><name><surname>Powell</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Apparent Genetic Rescue of Adult Shank3 Exon 21 Insertion Mutation Mice Tempered by Appropriate Control Experiments</article-title><source>ENeuro</source><volume>6</volume><elocation-id>2019</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0317-19.2019</pub-id><pub-id pub-id-type="pmid">31451607</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Splawski</surname><given-names>Igor</given-names></name><name><surname>Timothy</surname><given-names>KW</given-names></name><name><surname>Sharpe</surname><given-names>LM</given-names></name><name><surname>Decher</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Bloise</surname><given-names>R</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Joseph</surname><given-names>RM</given-names></name><name><surname>Condouris</surname><given-names>K</given-names></name><name><surname>Tager-Flusberg</surname><given-names>H</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</article-title><source>Cell</source><volume>119</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.09.011</pub-id><pub-id pub-id-type="pmid">15454078</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I</given-names></name><name><surname>Timothy</surname><given-names>KW</given-names></name><name><surname>Decher</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Sachse</surname><given-names>FB</given-names></name><name><surname>Beggs</surname><given-names>AH</given-names></name><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations</article-title><source>PNAS</source><volume>102</volume><fpage>8089</fpage><lpage>8096</lpage><pub-id pub-id-type="doi">10.1073/pnas.0502506102</pub-id><pub-id pub-id-type="pmid">15863612</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells</article-title><source>The Journal of Physiology</source><volume>385</volume><fpage>733</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1987.sp016517</pub-id><pub-id pub-id-type="pmid">2443676</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>AX</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>GGY</given-names></name><name><surname>Nai</surname><given-names>MH</given-names></name><name><surname>D’Agostino</surname><given-names>GA</given-names></name><name><surname>Tran</surname><given-names>H-D</given-names></name><name><surname>Itahana</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Lokman</surname><given-names>H</given-names></name><name><surname>Itahana</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>SWL</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>YY</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Cook</surname><given-names>SA</given-names></name><name><surname>Rackham</surname><given-names>OJL</given-names></name><name><surname>Lim</surname><given-names>CT</given-names></name><name><surname>Tan</surname><given-names>EK</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Lim</surname><given-names>KL</given-names></name><name><surname>Jiang</surname><given-names>Y-H</given-names></name><name><surname>Je</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Potassium channel dysfunction in human neuronal models of Angelman syndrome</article-title><source>Science (New York, N.Y.)</source><volume>366</volume><fpage>1486</fpage><lpage>1492</lpage><pub-id pub-id-type="doi">10.1126/science.aav5386</pub-id><pub-id pub-id-type="pmid">31857479</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatavarty</surname><given-names>V</given-names></name><name><surname>Torrado Pacheco</surname><given-names>A</given-names></name><name><surname>Groves Kuhnle</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Koundinya</surname><given-names>P</given-names></name><name><surname>Miska</surname><given-names>NJ</given-names></name><name><surname>Hengen</surname><given-names>KB</given-names></name><name><surname>Wagner</surname><given-names>FF</given-names></name><name><surname>Van Hooser</surname><given-names>SD</given-names></name><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Autism-Associated Shank3 Is Essential for Homeostatic Compensation in Rodent V1</article-title><source>Neuron</source><volume>106</volume><fpage>769</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.02.033</pub-id><pub-id pub-id-type="pmid">32199104</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZW</given-names></name><name><surname>Saifee</surname><given-names>O</given-names></name><name><surname>Nonet</surname><given-names>ML</given-names></name><name><surname>Salkoff</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>SLO-1 potassium channels control quantal content of neurotransmitter release at the <italic>C. elegans</italic> neuromuscular junction</article-title><source>Neuron</source><volume>32</volume><fpage>867</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00522-0</pub-id><pub-id pub-id-type="pmid">11738032</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>van der Goes</surname><given-names>M-S</given-names></name><name><surname>Hawrot</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>AY</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Zang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Lyman</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Gerfen</surname><given-names>CR</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism</article-title><source>The Journal of Clinical Investigation</source><volume>127</volume><fpage>1978</fpage><lpage>1990</lpage><pub-id pub-id-type="doi">10.1172/JCI87997</pub-id><pub-id pub-id-type="pmid">28414301</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witmer</surname><given-names>C</given-names></name><name><surname>Mattingly</surname><given-names>A</given-names></name><name><surname>DʼSouza</surname><given-names>P</given-names></name><name><surname>Thurm</surname><given-names>A</given-names></name><name><surname>Hadigan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Incontinence in Phelan-McDermid Syndrome</article-title><source>Journal of Pediatric Gastroenterology and Nutrition</source><volume>69</volume><fpage>e39</fpage><lpage>e42</lpage><pub-id pub-id-type="doi">10.1097/MPG.0000000000002342</pub-id><pub-id pub-id-type="pmid">30921255</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>H-R</given-names></name><name><surname>Gee</surname><given-names>HY</given-names></name><name><surname>Mah</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>J-I</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Ha</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>C</given-names></name><name><surname>Jung</surname><given-names>ES</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>S-G</given-names></name><name><surname>Lee</surname><given-names>J-S</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Bae</surname><given-names>YC</given-names></name><name><surname>Kaang</surname><given-names>B-K</given-names></name><name><surname>Lee</surname><given-names>MG</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</article-title><source>Nature</source><volume>486</volume><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/nature11208</pub-id><pub-id pub-id-type="pmid">22699620</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazejian</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>XP</given-names></name><name><surname>Grinnell</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tracking presynaptic Ca2+ dynamics during neurotransmitter release with Ca2+-activated K+ channels</article-title><source>Nature Neuroscience</source><volume>3</volume><fpage>566</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/75737</pub-id><pub-id pub-id-type="pmid">10816312</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Danko</surname><given-names>T</given-names></name><name><surname>Botelho</surname><given-names>SC</given-names></name><name><surname>Patzke</surname><given-names>C</given-names></name><name><surname>Pak</surname><given-names>C</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons</article-title><source>Science (New York, N.Y.)</source><volume>352</volume><elocation-id>aaf2669</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaf2669</pub-id><pub-id pub-id-type="pmid">26966193</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>A</given-names></name><name><surname>Dourado</surname><given-names>M</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Walton</surname><given-names>N</given-names></name><name><surname>Wei</surname><given-names>A</given-names></name><name><surname>Salkoff</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>SLO-2, a K+ channel with an unusual Cl- dependence</article-title><source>Nature Neuroscience</source><volume>3</volume><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1038/77670</pub-id><pub-id pub-id-type="pmid">10903569</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Maximov</surname><given-names>A</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>TS</given-names></name><name><surname>Tkatch</surname><given-names>T</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Association of CaV1.3 L-type calcium channels with Shank</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>1037</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4554-04.2005</pub-id><pub-id pub-id-type="pmid">15689539</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Kaiser</surname><given-names>T</given-names></name><name><surname>Monteiro</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Van der Goes</surname><given-names>MS</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Barak</surname><given-names>B</given-names></name><name><surname>Zeng</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Wells</surname><given-names>M</given-names></name><name><surname>Amaya</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><name><surname>Sanjana</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects</article-title><source>Neuron</source><volume>89</volume><fpage>147</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.11.023</pub-id><pub-id pub-id-type="pmid">26687841</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Idikuda</surname><given-names>VK</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Waite</surname><given-names>CB</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Shank3-deficient thalamocortical neurons show HCN channelopathy and alterations in intrinsic electrical properties</article-title><source>The Journal of Physiology</source><volume>596</volume><fpage>1259</fpage><lpage>1276</lpage><pub-id pub-id-type="doi">10.1113/JP275147</pub-id><pub-id pub-id-type="pmid">29327340</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75140.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Graeme W</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>University of California, San Francisco</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>Mutations altering the scaffolding protein Shank are linked to several psychiatric disorders. Here the authors take advantage of <italic>C. elegans</italic> genetics and muscle physiology to demonstrate that Shank binds CaV1 voltage activated calcium channels and promotes CaV1 coupling to calcium activated potassium channels.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75140.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Davis</surname><given-names>Graeme W</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>University of California, San Francisco</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Davis</surname><given-names>Graeme W</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>University of California, San Francisco</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Shank promotes action potential repolarization by recruiting BK channels to calcium nanodomains&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Graeme W Davis as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Piali Sengupta as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Summary: The authors have assembled a compelling study annotating the function of <italic>C. elegans</italic> Shank protein at discrete specializations in skeletal muscle, acting to couple calcium influx to BK channel function. Shank mutations, by altering the organization of these specializations, lead to altered calcium-driven action potential waveforms and muscle activation. The reviewers consider the work well executed and nicely presented. Major concerns address a few outstanding issues to clarify or strengthen specific points in the manuscript, all of which should be easily achieved. Additional critiques are focused on text revision to enhance clarity and acknowledge specific issues. Again, these are straightforward suggestions. The authors should be congratulated on a nice study.</p><p>Major Concerns:</p><p>1. Figures 2C and D: using floxed (nu697) or flexed (nu652) shn-1 alleles, they show that expressing CRE in muscles enhances PP rate and AP width, while expressing CRE in neurons has no effect on PP rate and a moderate, but not significant effect on AP width. Could it be that shn-1 affects muscle AP through a function in both tissues? This may be addressed by expressing CRE simultaneously in neurons and muscle to test if PP rate or AP width are further enhanced/rescued. Also, it appears that the authors omitted the control expressing CRE in neurons of nu652, which will strengthen the conclusions.</p><p>2. Figure 3 could be strengthened by including analysis of ∆VTTL; ∆PDZ double mutants. The findings will support that these two domains indeed interact with each other, as opposed to the idea that each domain mediates a different task, each incrementally affecting AP repolarization.</p><p>3. Figure 5A-B implies potassium currents are mediated by 2 sources, one channel composed of SLO-1/SLO-2 and another homomeric SLO-2. The finding in Figure 5C-D that SLO-2 signals are reduced in the absence of SLO-1 implies that the remaining GFP signals may represent SLO-2 homomers. If SLO-1 is exclusively heterodimer with SLO-2, how do the authors explain the observation that SLO-1 signals are unchanged in slo-2 mutants? Based on the data, it remains possible that functioning SLO-1 containing channels are not required for repolarization and instead, SLO-1 is only required for SLO-2 trafficking or localization. The statement that &quot;..these results suggest that rapid muscle repolarization following Aps is mediated by SLO1/2 heteromeric channels.&quot; The authors should acknowledge that SLO-2 homomers may also support rapid repolarization.</p><p>4. Figure 6D-E: The authors suggest that SHN-1 stabilizes SLO to nearby EGL-19 channels to link Ca to K currents. However, they also observe that ∆VTTL does not affect SLO-2 currents. While the authors address this contradiction in their discussion, a test of the AP phenotypes in egl-19∆VTTL; slo-2 double mutants compared to the singles (related to point 2 about the Figure 3 analysis) would help rule out any SLO-2 independent role for the egl-19 VTTL domain.</p><p>5. Table 2 is a list of alleles used or generated. The authors should also include a comprehensive list of strains used in this study.</p><p>6. Figures 2 and 3. The only data in the manuscript that are less than completely compelling are the assessments of PP rate where a subset of recordings seem to be affected and the changes are generally less than 1/10th of a Hz. The effect seems to reach high levels of significance due to the fact that the rate is near zero in controls (as well as a large number of the mutant recordings). There is a disruption, but the relevance here to muscle and animal function is a bit hard to understand. This should be clarified in the text and, perhaps, the authors could consider other aspects of the data that could be quantified – charge comes to mind.</p><p>7. Action potentials. These are slow, calcium-driven, muscle action potentials. The most appropriate reference point is probably cardiac muscle. The implicit assertion that there is direct relevance to sodium-driven action potentials in the CNS should be revised and broadened to non-neuronal muscle. This need not diminish the relevance of the work – in fact it may broaden the relevance.</p><p>8. The emphasis on nano-domain organization is problematic. As I understand, the sites of protein co-localization represent large micro-domains within the muscle t-tubule system. Obviously, nano-domains are relevant in mammalian neurons to couple calcium entry to BK channel function in both time and space during the sub-millisecond kinetics of the sodium action potential. The tight temporal coupling demands physical coupling. Work at the frog NMJ, imaging calcium domains, argues that the size of calcium domains at sites of entry are approx. 1.5µm and this size is not influenced significantly by the presence of EGTA. Given the much slower temporal dynamics of the <italic>C. elegans</italic> muscle action potential, and the large size of the protein micro-domains, I do not fully understand the argument for nano-domain coupling. This should probably be revised.</p><p>9. The muscle sites seem to be coincident with T-tubule domains. Can the authors provide evidence of other resident markers that do, or do not change? This will provide more general relevance and give a sense of whether there is broad-based disorganization of these sites versus specific effects on the channels focused on in the text.</p><p>10. The authors imply that shank, CaV1, and the Slo's form a functional complex in the muscle membrane, but the data are somewhat indirect. It would be useful if the authors could spell this out better so the reader can assess the strength of this inference. Is there direct evidence (pull-downs, etc) for such a 3-way complex?<italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Technically, the paper from the Kaplan rests on solid ground. An array of mutations and transgenic lines are used in the study the Shank gene, and are nicely documented. The electrophysiological assessment of ionic currents in <italic>C. elegans</italic> muscle is clear and well documented. Finally, the light-level protein localization analyses are clear and well documented. The authors cleanly define a set of phenotypes caused by mutations in the Shank gene, influencing muscle action potentials in <italic>C. elegans</italic>.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors use <italic>C. elegans</italic> to explore the relationship between shank, CaV1 (Ca) channels, and BK (slo) calcium-dependent K channels in controlling muscle excitability. They use a range of genetic approaches to mutate or knock out one or more of these players and assess the impact on muscle action potential generation and slo currents. Their data show that shank controls AP width and plateau potential generation (pp) through Slo channels, and this effect is cell-autonomous in muscle. They go on to suggest this effect is mediated through CaV1-slo coupling, by using previously characterized mutant that reduce this binding. Because these mutations may affect binding with other partners, these experiments do not unequivocally implicate direct binding between these three players; however, use of fast and slow Ca buffers also suggests that shank keeps CaV1 and slo in close association, presumably allowing Ca influx through CaV1 channels to effectively activate slo channels. Finally, they show that overexpression of shank has a similar impact on excitability as reduction; this is somewhat puzzling and not further explored mechanistically, but is interesting given gene dosage effects of shanks in humans.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Gao et al., present a nice set of data, using electrophysiology and molecular genetics, to address the function of <italic>C. elegans</italic> Shank (shn-1) in shaping muscle action potentials. Using genome-edited Cre-dependent deletion and expression of SHN-1, they show that removal of shn-1 specifically in body muscle widens the duration of action potentials and increases prolonged depolarization events known as plateau potentials (PP). They provide new evidence that SHN-1 couples the activity of the calcium channel EGL-19 to that of the BK potassium channels SLO-1/2. They additionally reveal that action potentials are sensitive to SHN-1 dosage. The experiments are generally conducted rigorously, and conclusions are stated appropriately. The findings offer insights into how human Shank misexpression might contribute to neurological disorder.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75140.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Major Concerns:</p><p>1. Figures 2C and D: using floxed (nu697) or flexed (nu652) shn-1 alleles, they show that expressing CRE in muscles enhances PP rate and AP width, while expressing CRE in neurons has no effect on PP rate and a moderate, but not significant effect on AP width. Could it be that shn-1 affects muscle AP through a function in both tissues? This may be addressed by expressing CRE simultaneously in neurons and muscle to test if PP rate or AP width are further enhanced/rescued. Also, it appears that the authors omitted the control expressing CRE in neurons of nu652, which will strengthen the conclusions.</p></disp-quote><p>As requested, we now analyze AP firing patterns following neuronal CRE expression in <italic>nu652</italic> (Figure 2). These data are described in the revised text, as follows:</p><p>Page 8:</p><p>“By contrast, <italic>shn-1</italic>(neuron KO) and <italic>shn-1</italic>(neuron rescue) had no effect on PP rate or AP widths (Figure 2C-D).”</p><disp-quote content-type="editor-comment"><p>2. Figure 3 could be strengthened by including analysis of ∆VTTL; ∆PDZ double mutants. The findings will support that these two domains indeed interact with each other, as opposed to the idea that each domain mediates a different task, each incrementally affecting AP repolarization.</p></disp-quote><p>To address this concern, we now analyze ΔVTTL; <italic>shn-1(null)</italic> double mutants. Because the <italic>shn-1</italic> null has a stronger SLO channel defect than the ΔPDZ mutant, we thought it would be better to analyze this double mutant. These new results are described as follows:</p><p>Page 8 (results):</p><p>“Furthermore, the <italic>shn-1(nu712</italic> null<italic>)</italic> and <italic>egl-19(nu496</italic> ΔVTTL<italic>)</italic> mutations did not have additive effects on PP rate and AP widths in double mutants (Figure 3, supplement 2).”</p><disp-quote content-type="editor-comment"><p>3. Figure 5A-B implies potassium currents are mediated by 2 sources, one channel composed of SLO-1/SLO-2 and another homomeric SLO-2. The finding in Figure 5C-D that SLO-2 signals are reduced in the absence of SLO-1 implies that the remaining GFP signals may represent SLO-2 homomers. If SLO-1 is exclusively heterodimer with SLO-2, how do the authors explain the observation that SLO-1 signals are unchanged in slo-2 mutants? Based on the data, it remains possible that functioning SLO-1 containing channels are not required for repolarization and instead, SLO-1 is only required for SLO-2 trafficking or localization. The statement that &quot;..these results suggest that rapid muscle repolarization following Aps is mediated by SLO1/2 heteromeric channels.&quot; The authors should acknowledge that SLO-2 homomers may also support rapid repolarization.</p></disp-quote><p>The text was revised as recommended:</p><p>Page 11:</p><p>“Collectively, these results suggest that rapid muscle repolarization following APs is mediated by SLO-1/2 heteromeric channels and by SLO-2 homomers.”</p><disp-quote content-type="editor-comment"><p>4. Figure 6D-E: The authors suggest that SHN-1 stabilizes SLO to nearby EGL-19 channels to link Ca to K currents. However, they also observe that ∆VTTL does not affect SLO-2 currents. While the authors address this contradiction in their discussion, a test of the AP phenotypes in egl-19∆VTTL; slo-2 double mutants compared to the singles (related to point 2 about the Figure 3 analysis) would help rule out any SLO-2 independent role for the egl-19 VTTL domain.</p></disp-quote><p>The requested experiment was included in the original submission. These results are described in the text as follows:</p><p>Page 11:</p><p>“Consistent with this idea, AP widths in <italic>slo-2</italic> single mutants were not significantly different from those in <italic>slo-2</italic> double mutants containing <italic>shn-1(nu712</italic> null), <italic>shn-1(nu542</italic> ΔPDZ), or <italic>egl-19(nu496</italic> ΔVTTL) mutations (Figure 6A).”</p><disp-quote content-type="editor-comment"><p>5. Table 2 is a list of alleles used or generated. The authors should also include a comprehensive list of strains used in this study.</p></disp-quote><p>A complete list of strains utilized is now provided in the Key Resource Table.</p><disp-quote content-type="editor-comment"><p>6. Figures 2 and 3. The only data in the manuscript that are less than completely compelling are the assessments of PP rate where a subset of recordings seem to be affected and the changes are generally less than 1/10th of a Hz. The effect seems to reach high levels of significance due to the fact that the rate is near zero in controls (as well as a large number of the mutant recordings). There is a disruption, but the relevance here to muscle and animal function is a bit hard to understand. This should be clarified in the text and, perhaps, the authors could consider other aspects of the data that could be quantified – charge comes to mind.</p></disp-quote><p>We agree that identifying a physiological significance for the muscle plateau potentials (PPs) would be interesting. Experimentally, this would require a mutation (or drug) that blocks SHK-1/KCNA inactivation (thereby reducing PP rate). Given that we lack such a mutant (or drug), we have no data examining this issue; consequently, we would rather not speculate about this. Nonetheless, we believe that readers will find it helpful if the text comments on PPs and SHN-1’s impact on them because PPs are a salient feature of our AP recordings.</p><disp-quote content-type="editor-comment"><p>7. Action potentials. These are slow, calcium-driven, muscle action potentials. The most appropriate reference point is probably cardiac muscle. The implicit assertion that there is direct relevance to sodium-driven action potentials in the CNS should be revised and broadened to non-neuronal muscle. This need not diminish the relevance of the work – in fact it may broaden the relevance.</p></disp-quote><p>We agree that CaV-BK coupling is unlikely to alter sodium-driven APs; however, we cannot find anywhere in the text where this possibility is suggested (or implied). If the reviewer can point out a specific comment that should be revised, we will be happy to do so. Instead, we list several potential effects of altered CaV-BK coupling on neuron and muscle physiology:</p><p>Pages 16-17:</p><p>“Shank regulation of BK channels could have broad effects on neuron and muscle function. In neurons, BK channels are functionally coupled to CaV channels in the soma and dendrites, thereby regulating AP firing patterns and somatodendritic calcium transients Golding et al., 1999Storm, 1987(; ). In pre-synaptic terminals, BK channels limit the duration of calcium influx during APs, thereby decreasing neurotransmitter release Griguoli et al., 2016Yazejian et al., 2000(; ). In muscles, BK channels regulate AP firing patterns, calcium influx during APs, and muscle contraction Dopico et al., 2018Latorre et al., 2017(; ). Thus, Shank mutations could broadly alter neuron and muscle function via changes in CaV-BK coupling.”</p><disp-quote content-type="editor-comment"><p>8. The emphasis on nano-domain organization is problematic. As I understand, the sites of protein co-localization represent large micro-domains within the muscle t-tubule system. Obviously, nano-domains are relevant in mammalian neurons to couple calcium entry to BK channel function in both time and space during the sub-millisecond kinetics of the sodium action potential. The tight temporal coupling demands physical coupling. Work at the frog NMJ, imaging calcium domains, argues that the size of calcium domains at sites of entry are approx. 1.5µm and this size is not influenced significantly by the presence of EGTA. Given the much slower temporal dynamics of the <italic>C. elegans</italic> muscle action potential, and the large size of the protein micro-domains, I do not fully understand the argument for nano-domain coupling. This should probably be revised.</p></disp-quote><p>We thank the reviewers for this comment. As recommended, we replaced nano-domain with micro-domain throughout the text (including the title).</p><disp-quote content-type="editor-comment"><p>9. The muscle sites seem to be coincident with T-tubule domains. Can the authors provide evidence of other resident markers that do, or do not change? This will provide more general relevance and give a sense of whether there is broad-based disorganization of these sites versus specific effects on the channels focused on in the text.</p></disp-quote><p>As suggested, we now analyze SHN-1’s impact on three additional junctional markers (SLO-1, EGL-19, and UNC-68). These results are described as follows:</p><p>Page 13:</p><p>“Next, we asked if inactivating SHN-1 alters the localization of other muscle ion channels. SLO-1 puncta intensity was unaltered in <italic>shn-1</italic> null mutants, indicating that BK channels lacking SLO-2 were trafficked normally (Figure 7 supplement 2A-B). In body muscles, EGL-19/CaV1 channels are extensively co-localized with calcium channels in the endoplasmic reticulum (ER), UNC-68/Ryanodine Receptors (RYR) Piggott et al., 2021(). However, the puncta intensity of endogenous EGL-19(Cherry<sub>11</sub>) and UNC-68(GFP<sub>11</sub>)/RYR in body muscles were unaltered in <italic>shn-1(nu712</italic> null) mutants (Figure 7H and Figure 7 supplement 2C-D), suggesting that SHN-1 does not broadly regulate co-localization of ion channels at ER-plasma membrane junctional contacts.”</p><disp-quote content-type="editor-comment"><p>10. The authors imply that shank, CaV1, and the Slo's form a functional complex in the muscle membrane, but the data are somewhat indirect. It would be useful if the authors could spell this out better so the reader can assess the strength of this inference. Is there direct evidence (pull-downs, etc) for such a 3-way complex?</p></disp-quote><p>The text was revised as suggested:</p><p>Page 18:</p><p>“Although SHN-1 binds EGL-19, SHN-1 may not directly link EGL-19 to SLO/BK channels. Instead, SHN-1 may link EGL-19 to other proteins required for SLO channel localization, e.g. components of the dystrophin complex Kim et al., 2009Sancar et al., 2011(; ).”</p></body></sub-article></article>